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Summary 
The importance of small antimicrobial peptides in the innate immune system of plants 
became increasingly apparent over the past decade. Antimicrobial peptides are unique 
and diverse molecules that are found in many tissue types in a variety of invertebrate, 
plant and animal species. Many of these peptides, such as plant defensins, have been 
found to be ubiquitous throughout the plant kingdom and have been isolated from 
flowers, leaves, roots, seeds, seedlings, pods, tubers and bark.  
The growing relevance of antimicrobial peptides (including plant defensins) in 
research can be largely attributed to their broad-spectrum antifungal activity. This 
makes them promising potential targets, both as therapeutic agents and for their use in 
crop protection and disease resistance. The continuing discovery of novel antimicrobial 
peptides has advanced the development of strategies to overexpress these genes in 
plants to attempt to enhance the plant’s natural ability to resist pathogenic attack. 
The first grapevine antifungal peptide, Vv-AMP1, was isolated and characterized 
and was shown to be tissue specific and developmentally regulated, being expressed 
only in berries at the onset of berry ripening. The peptide showed strong antifungal 
activity against a number of plant pathogenic fungi in vitro. In this study, the biological 
role of the Vv-AMP1 peptide was further investigated, both within its native host (Vitis 
vinifera) and under in vitro conditions against a panel of grapevine-specific pathogens. 
As a first step, recombinant production of Vv-AMP1 using an existing bacterial 
expression system was evaluated and the heterologous production of the Vv-AMP1 
peptide improved. Specific optimizations targeting both production and purification of 
the peptide showed to improve the yield of Vv-AMP1. Steps in the production process 
targeted for improvement included induction conditions of peptide production by the 
bacterial culture as well as a number of purification steps, such as lysate preparation, 
binding conditions, column washing, elution conditions and thrombin protease cleavage. 
The optimized purification method produced up to 3 mg of pure Vv-AMP1 peptide from 
1.6 L of overnight culture. While production was markedly improved, the resultant 
purified Vv-AMP1 proved biologically inactive and structurally unstable. This is 
uncharacteristic of the peptide, suggesting that an important aspect necessary for 
peptide activity, such as folding or the presence of specific co-factors might not be 
supported in this non-host prokaryotic production system.  
The study also entailed the characterization and evaluation of the Vv-AMP1 
peptide against a panel of grapevine-specific pathogens that are culturable to 
 sporulating cultures using in vitro antifungal assays and microscopy analysis. Vv-AMP1 
showed strong inhibitory activity against all pathogens tested, inhibiting the growth of 
Diplodia seriata and Cylindrocarpon liriodendri by 50% at concentrations between 4.8 
µg/ml and 9.6 µg/ml. Phaemoniella chlamydospora and Phomopsis viticola proved 
particularly sensitive, with IC50 values of 5.5 µg/ml and 4.0 µg/ml respectively. 
Microscopy analysis of the effect of the Vv-AMP1 peptide on P. viticola showed a 
severe inhibition on fungal germination and growth. The peptide did not induce 
morphological changes in fungal hyphae but compromises the fungal membranes, 
supporting the theory that the peptide induces membrane permeabilization.  
Functional analysis of a transgenic V. vinifera (cv. Sultana) population 
overexpressing Vv-AMP1 was included in this study to provide the opportunity to study 
the in planta role of the peptide in its native host. The genetic characterization of the 
putative population included confirming gene integration and copy number through PCR 
and Southern blot analysis as well as gene expression through northern blot analysis. A 
confirmed transgenic population was evaluated for improved disease resistance against 
Botrytis cinerea as a first test organism in an attempt to link the overexpression of the 
Vv-AMP1 gene to a disease resistance phenotype. Observations of lesion type, average 
lesion size and further statistical analysis concluded that the transgenic population 
showed a definite, albeit slight, improved resistance when compared to the 
untransformed control lines. 
In conclusion, the study determined that Vv-AMP1 had a strong antifungal action 
against grapevine-specific pathogenic fungi when tested in vitro. A definite link could be 
established between the overexpression of Vv-AMP1 and a mild resistance phenotype 
within its native host plant. The characterized transgenic population is important for 
further work to evaluate the in planta activity of the peptide against more grapevine 
pathogens such as the stem pathogens that were proven sensitive and specifically 
those that cannot be cultured and are obligate pathogens, such as the downy and 
powdery mildews.  
 
 
  
Opsomming 
Die belang van klein antimikrobiese peptiede in die ingebore immuunstelsel van plante 
het tydens die afgelope dekade toenemend duidelik geraak. Antimikrobiese peptide is 
unieke en diverse molekules wat in verskeie weefseltipes in ‘n verskeidenheid van 
invertebraat-, plant- en dierspesies gevind word. Baie van hierdie peptiede, soos bv. 
“plant defensins”, word bevind om alomteenwoordig in die plantryk te wees en is reeds 
geïsoleer vanuit blomme, blare, wortels, sade, saailinge, peule, knolle en bas.  
Die toenemende belang van antimikrobiese peptiede (insluitend “plant defensins”) 
in navorsing kan grootliks toegeskryf word aan hul breë-spektrum antifungiese aktiwiteit. 
Hierdie eienskap maak hul belowende potensiële teikens, beide as terapeutiese 
middels asook vir gebruik in gewasbeskerming en siekteweerstand. Die voortdurende 
ontdekking van nuwe antimikrobiese peptiede bevorder tans die ontwikkeling van 
strategieë om hierdie gene in plante uit te druk in ‘n poging om die plant se natuurlike 
vermoeë om patogeniese aanval teen te staan te verbeter. 
Die eerste wingerd antifungale peptied, Vv-AMP1, is geïsoleer en gekarakteriseer 
as ‘n ontwikkelings-gereguleerde peptied wat slegs uitgedruk word in korrels, tydens die 
aanvang van bessie rypwording. Die peptied het tydens in vitro  toetse sterk antifungale 
aktiwiteit getoon teen ‘n verskeidenheid plant-patogeniese swamme. In hierdie studie 
word die biologiese rol van die Vv-AMP1 peptied verder ondersoek, beide binne sy 
natuurlike gasheerplant, (Vitis vinifera) asook onder in vitro kondisies teen ‘n paneel van 
wingerd-spesifieke patogene. 
As ‘n beginpunt is rekombinante produksie van Vv-AMP1 met behulp van ‘n 
bakteriële ekspressie sisteem evalueer en die hetereloë produksie van die Vv-AMP1 
peptied stelselmatig verbeter. Spesifieke optimerings het gefokus op beide die 
produksie en suiwering van die peptied en het die algehele opbrengs van Vv-AMP1 
verhoog. Spesifieke stappe wat in die produksieproses vir verbetering geteiken is sluit 
beide induksietoestande van peptiedproduksie deur die bakteriële kultuur in sowel as ‘n 
aantal suiweringsstappe, soos lisaatvoorbereiding, bindingskondisies, kolom 
wasstappe, eluasie kondisies en “thrombin” protease snyding in. Die optimale 
suiweringsmetode het tot 3 mg suiwer Vv-AMP1 peptied opgelewer vanaf ‘n 1.6 L 
oornag bakteriële kultuur. Hoewel die produksie van die peptide noemenswaardig 
verbeter is, was die gesuiwerde Vv-AMP1 beide onaktief en struktureel onstabiel. Dit is 
buitengewoon vir hierdie peptied, wat daarop dui dat belangrike aspekte benodig vir 
 antifungiese aktiwiteit, soos korrekte vou of die teenwoordigheid van spesifieke ko-
faktore, moontlik ontbreek in hierdie nie-gasheer prokariotiese produksiesisteem.  
Die studie het ook die karakterisering en evaluering van die Vv-AMP1 peptied teen 
'n paneel van wingerd-spesifieke patogene wat kultureerbaar is en sporuleer, insluitend 
in vitro antifungale toetse en mikroskopiese analise, behels. Vv-AMP1 toon sterk 
inhiberende aktiwiteit teen alle patogene getoets. Dit inhibeer die groei van Diplodia 
seriata en Cylindrocarpon liriodendri met 50% teen konsentrasies tussen 4.8 µg/ml en 
9.6 µg/ml. Phaemoniella chlamydospora en Phomopsis viticola was besonders 
sensitief, met IC50 waardes van 5.5 µg/ml en 4.0 µg/ml, onderskeidelik. Mikroskopiese 
analise van die effek van die Vv-AMP1 peptied op P. viticola het 'n ernstige inhibisie op 
swam ontkieming en groei aangedui. Die peptied het geen morfologiese veranderinge in 
swam hifes veroorsaak nie maar het wel die swam membraan beskadig. Hierdie 
bevinding ondersteun die teorie dat die peptied membraan permeabilisasie induseer. 
Funksionele analise van ‘n transgeniese V. vinifera (cv. Sultana) populasie wat die 
Vv-AMP1 geen ooruitdruk is by die studie ingesluit om ‘n geleentheid te bied om die in 
planta rol van die peptide binne sy natuurlike gasheerplant te bestudeer. Die genetiese 
karakterisering van die vermeende transgeniese bevolking het die bevestiging van 
beide geenintegrasie en kopiegetal deur PKR en Southern-klad analise ingesluit, sowel 
as geenuitdrukking d.m.v. noordelike-klad analise. ‘n Bevestigde transgeniese bevolking 
is evalueer vir potensiële verbeterde weerstand (in vergelyking met die wilde tipe) deur 
infeksie met Botrytis cinerea as ‘n eerste toetsorganisme in ‘n poging om ‘n 
weerstandbiedende fenotipe met die ooruitdrukking van Vv-AMP1 te assosieer.  
Waarnemings van letsel tipe, letsel grootte en verdere statistiese analise het tot die 
gevolgtrekking gelei dat die transgeniese bevolking ‘n definitiewe (dog geringe) 
verbeterde weerstand toon in vergelyking met die ongetransformeerde lyne.  
Ten slotte bepaal die studie dat Vv-AMP1 ‘n sterk antifungale effek teen wingerd-
spesifieke patogene toon tydens in vitro toetse. ‘n Definitiewe korrelasie is vasgestel 
tussen die ooruitdrukking van Vv-AMP1 in wingerd en ‘n weerstandsfenotipe in die 
transgeniese bevolking. Die gekarakteriseerde transgeniese bevolking is uiteraard 
belangrik vir toekomstige werk om die in planta aktiwiteit van die peptied te evalueer 
teen verdere wingerdpatogene soos bv. die stampatogene wat sensitief getoets het 
teen die peptide, asook patogene wat nie kultureerbaar is nie, insluitend verpligte 
patogene soos dons- en poeierskimmel. 
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2 
GENERAL INTRODUCTION AND PROJECT AIMS 
1.1 INTRODUCTION 
Since the onset of organized agriculture, plant disease caused by viruses, fungi and 
bacteria have affected crops of all types, causing major losses a negative effect on 
crop quality. At present, agricultural disease control is mainly anchored in the use of 
chemicals to lessen the damage (Shah, 1997; Agrios, 2005). Modern agriculture also 
applies crop rotation as means of crop protection, but despite all these measures 
many pathogens prove formidable adversaries. Moreover, many pathogens are 
developing resistance to certain fungicides and some treatments are proving 
increasingly ineffective to decrease the occurrence of disease (Staub, 1991).  
While the development of new and improved methods of crop protection are 
essential, the focus of these methods must also be to comply with the safety 
concerns considering the potential negative impact many of these chemicals have on 
human health and the environment (Colosio et al., 2008). In addition to safety 
concerns, methods must also prove to be cost-effective. Spraying with chemicals is a 
costly process, and often the treatment must be repeated to be effective (Staub, 
1991; Ma and Michailides, 2005).  
 This situation is especially relevant to grapevine, the world’s most important and 
widely cultivated fruit crop (Vivier and Pretorius, 2002). Worldwide, the majority of 
commercially important grapes are constituted by different cultivars of Vitis vinifera. 
The rest are other species of Vitis or interspecific hybrids. Seventy percent of grapes 
produced are used for wine, 22% for table grapes and 8% for raisins. There are also 
a number of by-products or derivatives of the wine industry that have economic 
importance, such as must, marc distillates, marc pulp, tartaric acid, seed oil and 
vinegar (Troggio et al., 2008). V. vinifera is susceptible to fungal pathogens, carrying 
no innate resistance to mildew fungi such as powdery (Uncinula necator) and downy 
mildew (Plasmapora viticola), and also to microbial and viral attack (Figueiredo et al., 
2008). This necessitates the use of regular and intense spraying of phytochemicals, 
at great costs, both monetary and environmentally. These negative aspects drive 
research into alternative methods to enhance the plant’s innate defense system (Le 
Henanff et al., 2009). 
3 
With the commencement of the molecular era of plant biology in the early 
1980’s, a large part of research has been dedicated to genetically engineer crops for 
improved disease resistance (Day, 1986; Tuzun et al., 2006). During the last 30 
years, technology surrounding plant transformation and regeneration in general has 
improved dramatically (Vidal et al., 2009; Prado et al., 2010). Grapevine is a 
particularly difficult plant to transform, with established protocols involving complex 
procedures requiring specialized expertise. Even though many of these protocols are 
established, most have low transformation efficiency (Reustle and Buchholz, 2009). 
Methods for genetic transformation of grapevine have progressed and been 
developed extensively since the first successful transformations in 1989 (Baribault et 
al., 1989). Many research groups dedicate their work to improving the efficiency of 
transformation protocols and the improvement of transformation procedures. 
Improved, detailed protocols for both Agrobacterium-mediated transformation 
(Bouquet et al., 2006) and biolistic bombardment (Kikkert et al., 2005) have been 
published (Reustle and Buchholz, 2009).  
In addition to focusing on the improvement of grapevine transformation methods, 
most transgenic grapevine research aims to improve physiological traits but also 
establish resistance against viruses, fungi and bacteria (Reustle and Buchholz, 
2009). 
Identifying, cloning and characterizing genes involved in disease resistance has 
been improving significantly in recent years (Hollaender et al., 1985; Tuzun et al., 
2006). These genes are often targeted as transgenes for the genetic improvement of 
crops due to their potential to improve the plant’s ability to defend itself against 
pathogens. Plant defensins are small, basic antimicrobial peptides that form part of 
the innate immune system. They are functionally related to other defensins found in 
insects and mammals and seem to be ubiquitous throughout the plant kingdom, 
having been described in a number of diverse plant species (Carvalho and Gomes, 
2009). Plant defensins exhibit a broad range antifungal action but are nontoxic to 
mammalian and plant cells. They are produced through transcription and translation 
of a single gene, which means their delivery after infection is rapid and with relatively 
low input of biomass and energy (Thomma et al., 2002). 
Through advances in molecular screening techniques, the discovery of plant 
defensins has been increasing exponentially in recent years. It has been proposed 
that the number of defensin-like genes in plants is greatly under-predicted (Graham 
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et al., 2004; Silverstein et al., 2005). In recent years, this has proven to be an 
accurate postulation. The difficulty in accurately predicting these genes is linked to 
the extreme sequence diversity within these gene families, with most molecular 
techniques only being able to identify closely related sequences (Graham et al., 
2008). With the development of genome-scale sequencing technology, whole-
genome analysis is now more readily available to researchers. In addition, the 
availability of fully sequenced plant genomes allows whole genome analysis using 
expressed sequence tag (EST) libraries. Many agriculturally important crops such as 
Oryza sativa (rice), Sorghum bicolour (sorghum), Zea mays (corn), Malus domestica 
(apple) and V. vinifera (grapevine) have fully sequenced genomes, enabling more 
targeted research strategies. 
These advances in genome analysis have led to the re-evaluation of previous 
findings related to defensin-like genes in plants. Graham et al. (2004) showed that 
plant genomes typically have hundreds of defensin-like genes. In the Arabidopsis 
genome alone, more than 300 defensin-like peptides have been identified, 78% of 
which possess the characteristic cysteine-stabilized α-helix β-sheet (CSαβ) motif, 
common in all plant and invertebrate defensins (Thomma et al., 2002; Silverstein et 
al., 2005). This is in severe contrast to the 15 defensins previously described in 
Arabidopsis (Thomma et al., 2002). Considering the size of the gene families, it 
suggests that our functional knowledge of defensins is still rather limited.  
 The continuing discovery of novel plant defensins has advanced the 
development of strategies to overexpress these genes in plants in an attempt to 
enhance the plant’s innate immunity and consequently improve resistance against 
pathogen attack.  In designing disease resistant crops, a resistant characteristic of 
a donor organism is transferred to the desired crop through recombinant DNA 
technology. A well-publicized example of crops engineered for pest resistance is 
cotton and maize, engineered to express and produce the Bt toxin (from Bacillus 
thuringiensis), which is poisonous to insect pests. While the crops produce the toxin 
in their tissue, the effects are targeted specifically to lepidopteron pests, purportedly 
with no effect on any other organisms in the surrounding soil, including earthworms, 
nematodes, protozoa, bacteria and fungi (Saxena and Stotzky, 2001). 
 Despite pervasive controversy surrounding transgenic crops and genetic 
engineering, both industrial and developing countries continue to plant more 
hectares of transgenic crops year after year. In 2009, 77% of the world’s soybean 
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crop was transgenic; 49% of cotton, 26% of maize and 21% of canola were all 
transgenic. Across the globe, transgenic crops made up 134 million hectares, which 
is an 80-fold increase from 1996 (Figure 1). This translates to a yearly growth of 9 
million hectares or 7%. In South Africa alone, the estimated total biotech crop was 
2.1 million hectares, which is mainly made up of soybean, maize and cotton. It has 
also been suggested that planting transgenic crops can lead to a reduction in CO2 
emissions resulting from fewer insecticide and herbicide sprays (James, 2009).  
Figure 1. Representation of the growth of transgenic or “biotech” crops between 
1996 and 2009. The map indicates countries, both industrial and developing, that 
use transgenic crops commercially. The term “trait hectare” refers to an area of 
transgenic crop containing stacked traits, and is calculated by multiplying the surface 
area with the number of GM traits in the crops. It is therefore not an indication of 
actual surface area but rather “virtual” hectares (James, 2009). 
 
While public opinion often mistrusts genetically modified crops, the benefits the 
technology offers seem to far outweigh the possible risks. Not only do some 
genetically engineered crops show improved resistance against disease, thereby 
lessening the need for harmful chemical treatments, but the possibility of an 
associated decrease in carbon emissions and the promise of food security for 
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developing countries more than confirms the need to further expand and improve the 
field.  
The use of transgenic technology is a powerful tool in many research areas, 
including agriculture and pharmacology. The ability to transfer genes and gene 
products between organisms or to alter expression of a native gene in a host 
organism allows the opportunity to further investigate the function and effects of the 
gene within the system. This study will continue the functional characterization of an 
antifungal peptide isolated from grapevine. Previously, the peptide was isolated and 
characterized in vitro and overexpressed in tobacco as an infection model plant (De 
Beer, 2008). This work will be extended by evaluating the activity against grapevine 
pathogens and overexpressing the peptide in its native host, grapevine.  
1.2 PROJECT AIMS 
The first grapevine defensin from V. vinifera was designated Vv-AMP1 (Vitis vinifera 
antimicrobial peptide 1) and was isolated and characterized by De Beer and Vivier 
(2008). The peptide encoding gene showed developmentally regulated, tissue 
specific expression, only being expressed in berries and at the onset of berry 
ripening and onwards. Expression of the Vv-AMP1 gene could not be induced by 
hormone treatment, wounding or infection. Further analyses revealed that the signal 
peptide allowed accumulation of the peptide in the apoplastic region. Recombinantly 
produced Vv-AMP1 had a molecular mass of 5.495 kDa, as determined by mass 
spectrometry. The peptide was extremely heat stable and showed strong antifungal 
activity against a range of plant pathogenic fungi. Vv-AMP1 was tested against 
Botrytis cinerea, Fusarium solani, F. oxysporum and Verticillium dahliae and 
inhibited 50% of fungal growth at concentrations of 13, 9.6, 6 and 1.8 µg/ml 
respectively. Although the peptide did have a damaging effect on fungal membranes, 
it did not induce morphological changes such as hyperbranching and was classified 
as non-morphogenic (De Beer and Vivier, 2008). 
Overexpression in tobacco and subsequent challenging of the population with 
B. cinerea did not lead to a resistance phenotype in a detached leaf assay. Although 
expression of the transgenes were confirmed,  it was not possible to detect the 
presence of Vv-AMP1 in the plant with Western blot, due to the presence of native 
peptides in tobacco that cross-reacted with the Vv-AMP1 polyclonal antibody (De 
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Beer, 2008). Questions remained regarding the in vivo function, activity and stability 
of the peptide, some of which will be pursued in this study.  
This project was initiated to further explore the biological role of the peptide 
when overexpressed within its native host as well as to evaluate the in vitro activity 
of the peptide against a panel of grapevine-specific pathogens. This required the 
recombinant production of pure Vv-AMP1 peptide for in vitro antifungal assays 
(according to a method by Broekaert et al., 1990) to determine the level of activity of 
the peptide against a panel of suitable grapevine-specific pathogens.  
A transgenic population of V. vinifera cv. Sultana transformed with a Vv-AMP1 
overexpression cassette was obtained from the Institute for Wine Biotechnology 
(IWBT) grapevine transformation and regeneration platform. This population will be 
phenotypically and genetically analyzed to evaluate the functional role of Vv-AMP1 in 
grapevine.  
 
The specific aims of the project were as follows: 
 
a. To recombinantly produce and evaluate purified Vv-AMP1 peptide  
i. Evaluation and optimization of a bacterial expression system 
ii. Heterologous production and purification of Vv-AMP1 peptide 
b. To evaluate and characterize the antifungal activity of the Vv-AMP1 peptide 
against a panel of grapevine specific pathogens 
i. In vitro antifungal assays to determine the specific IC50 values of the 
peptide against each pathogen 
ii. Microscopic analysis of the inhibition of Vv-AMP1 on the different 
pathogens to evaluate the mode of action 
c. The analysis of transgenic V. vinifera (cv. Sultana) lines overexpressing the 
Vv-AMP1 peptide 
i. Multiplication and maintenance of putatively transgenic lines to form a 
mother and working collection of in vitro and hardened off grapevine 
lines. Observation of the lines for any obvious visible phenotypes linked 
to the overexpression of the peptide  
ii. Genetic analysis of a putative transgenic population of V. vinifera 
transformed with Vv-AMP1 and the untransformed controls 
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 PCR and Southern blot analysis to determine gene integration 
and copy number 
 Northern blot analysis to determine gene expression 
 Assays to confirm peptide production and activity 
iii. Infection studies of the confirmed transgenic population and controls to 
evaluate potential resistance phenotype linked to the overexpression of 
the Vv-AMP1 gene in grapevine  
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LITERATURE REVIEW 
2.1 Introduction 
All living organisms are continuously exposed to potentially harmful microbes and 
pathogens. Despite this constant threat of infection, the occurrence of disease is the 
exception rather than the rule. The ability of multi-cellular organisms to withstand 
disease depends on their capacity to actively defend themselves against pathogen 
attack. As a result, all forms of life (including microbes) have evolved mechanisms of 
host defense, involving varied components and responses (Broekaert et al., 1997; 
Reddy et al., 2004; Linde et al., 2009).  
All types of organisms have to defend themselves against pathogens using one 
(or both) of two immune systems: nonspecific immunity or specific immunity. 
Nonspecific immunity is also referred to as innate immunity, pre-formed immunity, 
rapid immunity or simply as the host defense system. In all multicellular organisms, 
this type of immunity serves as the first line of defense against pathogen attack. 
Innate immunity utilizes a number of antimicrobial substances, ranging from 
inorganic chemicals (e.g. hydrogen peroxide, hypochlorous acid, nitric oxide) to 
enzymes (e.g. proteases, muramidases) and other proteins and peptides with 
antimicrobial action to prevent or restrict the ability of the invading microbes to 
establish infection (Ganz and Lehrer, 1995; Raj and Dentino, 2002; Nicolas and 
Rosenstein, 2009).  
Mechanisms of innate immunity are genetically predetermined and require no 
previous exposure to the specific pathogen (Boman, 1995; Izadpanah and Gallo, 
2005). Endogenous peptides involved in host defense are typically constitutively 
expressed, although some have been shown to be inducible. Effector molecules of 
innate immunity (whether chemical, enzymatic or peptides) are generally produced 
by the transcription and translation of a single gene. This allows rapid delivery of the 
gene product with very limited energy expense (Thomma et al., 2002). This non-
specific branch of host defense is conserved throughout both plant and animal 
kingdoms (including invertebrates and fungi) indicating its ancient origins (Brown and 
Hancock, 2006; Linde et al., 2009). 
 
13 
 
Figure 2.1 Evolution of immune defense systems. Innate immunity is generally considered 
the evolutionary most ancient of the two main branches of immunological defense systems 
dating back to the first multi-cellular organisms or earlier (note change in time scale – Byr 
billion years, Myr million years) (Adopted from Linde et al., 2009). 
Specific immunity (also known as adaptive or acquired immunity) is found 
exclusively in mammals. Compared to innate immunity, acquired immunity is a more 
recently evolved system of defense, found only in higher vertebrates (Figure 1). 
Acquired immunity is more complex than its ancient counterpart. It is both specific 
and has a memory function, enabling the organism to “remember” and recognize a 
specific pathogen through antigen recognition by antibodies (Izadpanah and Gallo, 
2005), facilitating it to deal more efficiently with subsequent challenges from the 
same organism (Broekaert et al., 1997; Linde et al., 2009). It does not rely on gene-
encoded products, but rather the activation of T and B cells against specific antigens 
(Reddy et al., 2004).  
Owing to the need for the host organism to first recognize the pathogen, the 
acquired immune response is slightly delayed. With microbes having a very short 
doubling time (some as quick as 20 minutes), this delay could prove detrimental to 
the host in allowing the pathogen enough time to establish infection. The rapid action 
of the innate immune response provides the host with almost immediate protection, 
without requiring activation of the adaptive immunity (Marshall and Arenas, 2003).  
Consequently, the importance of the innate immune response (or host defense) 
in preventing disease becomes clear, both in organisms with and without adaptive 
immune systems. Antifungal peptides form part of a large group of antimicrobial 
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peptides (AMPs). The former are significant role-players in the host defense system 
of both plants and animals and will form the subject of this review, with a specific 
focus on plant defensins. 
2.2 Classification of Antimicrobial peptides (AMPs) 
Antimicrobial peptides are diverse and unique molecules found in many tissue and 
cell types of a variety of invertebrate, plant and animal species (Figure 2). On 
account of their role as first line of defense against infection, they are most abundant 
in cells, tissues and organs that are constantly exposed to microbes (Schröder, 
1999). In animals they are prevalent in the cutaneous tissues, mucous membranes, 
respiratory tract lining fluids, skin, pancreas, kidney, salivary glands, prostate and 
endocervix (Raj and Dentino, 2002; Benko-Iseppon et al., 2010). In plants they have 
been isolated from flowers, leaves, seeds, seedlings, pods, tubers, roots and bark 
(Schröder, 1999; Lay and Anderson, 2005). Insect antimicrobial peptides are 
typically found in the haemolymph, the functional equivalent to blood (Otvos, 2000). 
Avian defense peptides are distributed similarly to those of mammals and have been 
isolated from epithelial cells; heterophils; peripheral leukocytes; the respiratory, 
digestive and urogenital tract and the skin (van Dijk et al., 2008). 
While the diversity and distribution of AMPs in the Eukaryotic domain is evident 
(see Figure 2), the different peptides (although dissimilar in details of their structure 
and function) all share a fundamental structural principle in their amphipathic design. 
Different classes of peptide achieve this through differing structural characteristics 
(e.g. cecropins and magainins assume an amphipathic α-helical structure when 
entering a membrane, while defensins possess a rigid anti-parallel β-sheet, 
stabilized by disulphide bonds) (Zasloff, 2002). 
AMP primary sequences are so diverse that the same sequence is rarely 
isolated from two different species of animal, even if they are closely related. There 
is, however, considerable conservation of amino acid sequences, even between 
different classes of peptides, different species and even across kingdoms (Zasloff, 
2002). 
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Figure 2.2 Distribution of antimicrobial peptides across the Eukaryote domain. AMPs are 
arranged according to kingdom, class and type of AMP (Compiled from Ganz and Lehrer, 
1995; Garcia-Olmedo et al., 1998; Bulet et al., 1999; Zasloff, 2002; Castro, 2005; van Dijk et 
al., 2008; Linde et al., 2009; Otero-Gonzalez et al., 2010). 
AMPs are generally classified into subgroups based on their size, 
conformational structure and predominant amino acid composition, as summarized 
in Table 1 (Zasloff, 2002; Marshall and Arenas, 2003). It has been noted that the 
AMPs are so diverse that categorization in one generally accepted classification is 
rather difficult (Koczulla and Bals, 2003). 
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Table 2.1 Classes of antimicrobial peptides according to amino acid composition and structure 
(adapted from Vizioli and Salzet, 2002; Zasloff, 2002). 
Structure Representative 
peptides 
Source 
organism 
Reference 
Anionic peptides Maximin H5 Toad (Lai et al., 2002; Diamond et al., 2009) 
 Dermcidin Human (Schittek et al., 2001; Lai et al., 2007) 
Linear α-helical 
peptides 
Cecropins Insects (Bulet et al., 1999; Coca et al., 2006; Jin et 
al., 2010) 
 Magainin Amphibians (Andreu and Rivas, 1998; Gregory et al., 
2009) 
 Buforins Amphibians (Park et al., 1996; Conlon, 2004; Hao et al., 
2009) 
Linear peptides rich in 
certain amino acids 
Proline-rich: 
- drosocin 
 
Fruit fly 
 
(Bulet et al., 1999; Bikker et al., 2006) 
 Glycine-rich: 
- diptericins 
 
Dipterans 
 
(Bulet et al., 1999; Johansson et al., 2006) 
 Histidine-rich: 
- histatin 
 
Human 
 
(Andreu and Rivas, 1998; Smet and 
Contreras, 2005) 
 Tryptophan-rich: 
- indolicidin 
 
Cattle 
 
(Andreu and Rivas, 1998; Rokitskaya et al., 
2010) 
Single disulfide bridges Brevinins Frog (Andreu and Rivas, 1998; Basir et al., 
2000; Conlon et al., 2009) 
Two disulfide bridges Protegrin Pig (Kokryakov et al., 1993; Bolintineanu et al., 
2010) 
 Tachyplesin Horseshoe 
crab 
(Dimarcq et al., 1998; Cirioni et al., 2007) 
 Androctonin Scorpion (Dimarcq et al., 1998) 
Three disulfide bridges α-defensins Mammals (Ganz and Lehrer, 1995; Hazrati et al., 
2006) 
 β-defensins Mammals (Ganz and Lehrer, 1995; Bullard et al., 
2008) 
 Insect defensins Insects (Dimarcq et al., 1998; Bulet et al., 1999; 
Aerts et al., 2008) 
 Penaeidins Shrimp (Destoumieux-Garzòn et al., 2001; Ho and 
Song, 2009) 
Four or more disulfide 
bridges 
Drosomycin Fruit fly (Fehlbaum et al., 1994; Zhang and Zhu, 
2009) 
 Plant defensins Plants (Fehlbaum et al., 1994; García-Olmedo et 
al., 1998; Benko-Iseppon et al., 2010) 
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2.3 AMP research – History and Relevance  
The correlation between microbes and disease dates back to the early 19th century. 
Robert Koch, Louis Pasteur and their contemporaries were the first to suggest the 
notion that microbes were the causal agents of food spoilage and disease. The work 
of Joseph Lister and Paul Ehlrich focused on the search for antimicrobial substances 
that could be used to combat microbial infection (Ganz, 2005). 
In 1929, Alexander Fleming identified lysozyme as the first enzyme showing 
antimicrobial properties. He also indicated that different forms of lysozyme were 
widely distributed throughout the plant and animal kingdoms (Fleming, 1922). In 
1932, his discovery of penicillin effectively sparked the beginning of antimicrobial 
research (Fleming, 1932; 1944). 
Throughout the 20th century, a number of antibiotic and antimicrobial 
substances have been discovered and isolated from insects (Hultmark et al., 1980), 
plants (García-Olmedo et al., 2001) and animals (Hirsch, 1956; Zeya and Spitznagel, 
1968). Towards the end of the century, improvements in molecular biology led to the 
conclusion that AMPs are encoded by gene families. It allowed the purification of 
individual peptides, the determination of their amino acid sequences and the cloning 
of the genes that encoded these peptides. By the mid-1990’s research on AMPs 
extended to invertebrates, vertebrates, plants and bacteria. In 1994, researchers 
from the various fields of AMP research met for the first time at a CIBA symposium in 
London (Ganz, 2005). Collaboration and interaction between the various research 
groups propelled the field of antimicrobial research forward, and publications on 
AMPs in recent years have increased significantly (Figure 3). 
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Figure 2.3 Publications on antimicrobial peptides. Relevant publications were identified by a 
web-based search in PubMed using the search term “antimicrobial peptide” (adapted from 
Koczulla and Bals, 2003). 
 
2.3.1 Growing importance of AMP research 
It is evident that antimicrobial peptide research has increased dramatically over the 
past decade and specifically in the last five years (Figure 3). This can largely be 
attributed to the recent recognition of the economic importance of these peptides. 
Their broad-spectrum activities make them suitable targets for development as 
therapeutic agents and for their potential use in crop protection and disease 
resistance (Shah, 1997; Reddy et al., 2004). 
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2.3.2 AMPs as promising therapeutics 
Since the industrial-scale production of penicillin started in 1943, the availability of 
antibiotics has had a profound effect on human life. It has contributed to an eight-
year increase in the average human lifespan and has allowed the successful 
treatment of bacterial infections which previously would have been injurious or even 
fatal (Hancock, 1998). 
Throughout the years however, bacterial strains have gradually adapted to 
become increasingly resistant to conventional antibiotics. For example, 95% of all 
Staphylococcus aureus strains tested are resistant to penicillin (Breithaupt, 1999). 
This alarming rise in antibiotic resistance (including the emergence of untreatable 
infections from multi-drug resistant strains of Mycobacterium tuberculosis and 
Enterococcus) highlights the need for novel antimicrobial agents (Hancock and 
Patrzykat, 2002). AMPs possess many desirable features as novel antimicrobial 
compounds: they possess a broad spectrum of activity, they kill bacteria rapidly and 
some show no toxicity towards eukaryotic cells (Hancock and Scott, 2000; Wilcox, 
2004). Nonetheless, there are still issues surrounding the use of AMPs as antibiotics 
that need to be solved, not least of which is cost-effective production. While there are 
several methods established for recombinant production of peptides, none have yet 
successfully been applied on an industrial scale (Hancock and Scott, 2000). 
Aside from their potential as antibiotics, AMPs also show potential as antiviral 
(acting against enveloped viruses such as hepatitis and HIV (Nakashima et al., 
1992), anticancer (some peptides actively attack cancer cells) (Moore et al., 1994); 
wound healing (Hancock, 1998) agents and even as contraceptives (Reddy et al., 
2004). 
To date, very few antimicrobial peptides have been entered into clinical trials, 
with varied success. One of the longest running and most successful trials to date is 
from Micrologix Biotech Inc. (now known as Migenix Inc., Vancouver, British 
Columbia, Canada). In 1999, they entered an indolicidin-like peptide, named MBI-
226 or Omiganan™, into Phase I (safety) trials. In 2000 they received fast-track 
status from the Food and Drug Administration. In 2002 they initiated two more 
clinical trials using indolicidin-like peptide, against acute acne and against methicillin-
resistant S. aureus (MRSA) (Hancock and Patrzykat, 2002; Portieles et al., 2006).  
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To date, Omiganan™ has been evaluated for two topical applications, for the 
treatment of catheter-related infections as well as the treatment of dermatological 
diseases. Two Phase III clinical trials have been completed for the treatment of 
catheter-related infections. The results did not meet the endpoint of the study and 
further development of the drug is being investigated. Two Phase II clinical trials 
have also been completed for Omiganan™ in the treatment of rosacea and acne. 
Enrollment in Phase III trials is currently pending (Migenix, 2009).  
 
2.3.3 Biotechnological application of AMPs 
Management and prevention of disease in food crops has become a global industry, 
dedicated to developing new and improved methods of preventing and controlling 
the incidence and spread of disease. Factors that negatively affect crops include 
disease, pests and weeds. These competing factors influence both the quality and 
quantity of crop production (Walker, 1983). In agriculture, disease caused by 
pathogens has become increasingly difficult to manage.  
 Current agricultural disease control is based on the spraying of chemicals 
(herbicides, pesticides and fungicides) to regulate and reduce the occurrence of 
disease-causing organisms. Spraying, however, is not a once-off treatment and must 
be regularly repeated to have a lasting effect. This is a costly process, and with 
many pathogens developing resistance to commonly used chemicals (Staub, 1991; 
Ma and Michailides, 2005), even regular treatment can prove ineffective to lessen 
the incidence of disease. 
 The excessive use of chemicals is becoming less desirable, not only because of 
the financial implications, but also owing to environmental concerns and potential 
negative impact on human health and safety. Studies have linked exposure to 
pesticides to diseases (Colosio et al., 2008) such as Parkinson’s disease (Ascherio 
et al., 2006), cancer (Landau-Ossondo et al., 2009), birth defects (Winchester et al., 
2009) and more directly, acute pesticide poisoning (Van Der Hoek et al., 1998).    
 In light of these concerns, research has been focused on increasing the disease 
resistance of crops against pathogen attack through alternative approaches that are 
less harmful to both humans and the environment. The most recent and notable 
approach is genetically engineering crops for resistance (Shah, 1997; Gao et al., 
2000; Kanzaki et al., 2002; Jacobsen et al., 2009).  
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Overexpressing genes encoding for antifungal peptides into crops may possibly 
enhance the plant’s natural ability to defend itself against infection. The active 
production of these antifungal peptides by the plant could provide the plant with the 
ability to inhibit fungal growth and slow down infection. The abundance of antifungal 
peptides that have been discovered to date provides a wide range to choose from 
when designing a transgenic strategy. 
 
Table 2.2 Plant defensins overexpressed in transgenic hosts (adapted from Lay et al., 2005) 
Transgene Source 
organism 
Recipient 
plant(s) 
Test organism(s) 
to evaluate 
resistance 
phenotypes 
Reference 
Rs-AFP2 Radish Tobacco Alternaria longipes (Terras et al., 
1995) 
AlfAFP Alfalfa Potato Verticillium dahliae (Gao et al., 2000) 
Spi1 Norway 
spruce 
Tobacco, 
Norway spruce 
embryonic 
cultures 
Erwinia carotovora, 
Heterobasidion 
annosum 
(Elfstrand et al., 
2001) 
BSD1 Chinese 
cabbage 
Tobacco Phytophthora 
parasitica 
(Park et al., 2002)
hBD-2 Human Arabidopsis 
thaliana 
B. cinerea (Aerts et al., 
2007) 
Vv-AMP1 Grapevine Tobacco B. cinerea (De Beer, 2008) 
     
Dm-AMP1 Dahlia merckii Rice Magnaporthe 
oryzae, Rhizoctonia 
solani 
(Sanjay et al., 
2009) 
Chili 
defensin 
Capsicuum 
annum 
Tomato Fusarium sp., 
Phytophthora 
infestans 
(Zainal et al., 
2009) 
 
Some of the best known and characterized plant AMPs are defensins. Plant 
defensins have been extensively targeted for enhanced resistance studies. Table 2 
lists a number of studies overexpressing plant defensins in transgenic hosts. These 
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studies are often carried out either in model systems (such as tobacco) or in 
economically important crops (such as rice or potato). In one of the first studies of its 
kind, the constitutive expression of radish defensin (Rs-AFP2) in tobacco enhanced 
the plant’s resistance to Alternaria longipes (Terras et al., 1995). An even more 
successful example of the ability of defensins to confer disease resistance to 
transgenic crops was the constitutive expression of alfAFP in potato. Not only did the 
transgenic lines show a six-fold decrease in the levels of Verticillium dahliae when 
compared to the non-transgenic plants, but this resistance was maintained under 
glasshouse conditions, field conditions and for several years thereafter (Gao et al., 
2000). More recently, the Dm-AMP1 defensin was overexpressed in rice and showed 
resistance against both Magnaporthe oryzae and R. solani. The expression of the 
peptide in the apoplastic regions of the tissue may cause it to interact directly with 
fungal membranes, leading to membrane destabilization and in doing so, imparting 
enhanced disease resistance against a broad range of fungal pathogens to the 
transgenic plants (Sanjay et al., 2009). Another promising study was the 
overexpression of a chili defensin gene in tomato. The resultant transgenic lines 
were more resistant to both Fusarium sp. and Phytophthora infestans, though further 
research is required to determine whether this approach would be an effective 
means of increasing disease resistance (Zainal et al., 2009). 
2.4 Concise overview of antifungal peptides in plants 
Antimicrobial peptides play a key role in plant defense against invading pathogens. 
They form part of pre-existing defense barriers and are also components of the 
defense response induced upon infection. Generally, a peptide is classified as 
antimicrobial if “it interferes with the growth, differentiation, multiplication and/or 
spread of microbial organisms”. Plant AMPs are classified into protein families based 
on homology, amino acid sequence and three-dimensional folding pattern (Broekaert 
et al., 2000). 
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2.4.1 Classification of plant antimicrobial peptides 
Plant-derived AMPs are diverse and possess a broad range of biological activity, 
including antibacterial (Zhang and Lewis, 1997), insecticidal (Chen et al., 2002), 
protein synthesis inhibition (Harrison et al., 1997), α-amylase inhibition (Bloch and 
Richardson, 1991) and anti-HIV (Wong, 2005; Wong and Ng, 2005). Yet, it is their 
antifungal activity that appears to be ubiquitous throughout all plant species. 
Selitrennikoff (2001) categorized antifungal proteins and peptides, based on their 
mechanisms of action, structure or similarity to other proteins (Table 3). Accordingly, 
the remainder of this review will focus mainly on antifungal plant peptides, 
specifically plant defensins. 
 
2.4.2 Antifungal peptides in plants 
Of the nearly countless plant antimicrobial proteins isolated to date, a large 
proportion share common characteristics. They are typically highly basic proteins of 
small molecular weight (<10 kDa) with an even number of cysteine residues 
(typically 4, 6 or 8) that stabilize the protein structure through formation of disulfide 
bridges and provide structural and thermodynamic stability to the protein (Hancock 
and Lehrer, 1998; Lay and Anderson, 2005; Benko-Iseppon et al., 2010). Bearing in 
mind the similarities between different types of peptides, a number of distinct families 
have been identified. They include plant defensins (Broekaert et al., 1995; Broekaert 
et al., 1997; Lay et al., 2003), thionins (Bohlmann et al., 1994; Florack and Stiekema, 
1994), lipid transfer proteins (Kader, 1996), hevein-type proteins (Broekaert et al., 
1992), knottin-type proteins (Cammue et al., 1992), cyclotides (Craik et al., 1999), 
four-cysteine peptides (e.g. Ib-AMPs from Impatiens balsamina seeds) (Lee et al., 
1999) and twelve-cysteine peptides (e.g. snakins) (Segura et al., 1999; Berrocal-
Lobo et al., 2002) (see Table 4 for a comparison of these families, as well as an 
indication of numbers of amino acids and disulfide bridges, as well as the protein 
structure). 
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Table 2.3 Classification of antifungal proteins (Selitrennikoff, 2001), co-reported in (Ferreira 
et al., 2007). The defensins are boxed in this classification. 
Class Source Characteristics Mechanism of Action 
PR-1 Proteins Plants Molecular masses of 
15-17 kDa 
Homology to 
cysteine-rich proteins 
Unknown 
β-glucanases Microorganisms, Plants 
Vertebrates, Invertebrates 
1,3-β-Endoglucanase 
activity 
Hydrolysis of the structural 1,3-
β-glucan present in the fungal 
cell wall 
Chitinases Viruses, Bacteria, Fungi, 
Snails, Fish, Plants, 
Insects, Mammals, 
Amphibians 
Chitinase activity 
Molecular masses of 
26-43 kDa 
Cleavage of cell wall chitin 
polymers 
Chitin-binding 
proteins 
Bacteria, Plants, Insects, 
Crustaceans 
Chitin-binding 
proteins 
Molecular masses of 
13-14.5 kDa 
Binding to cell wall β-chitin 
(mechanism not understood) 
Thaumatin-like 
proteins 
Plants Share significant 
sequence homology 
to thaumatin 
Molecular masses 
~22 kDa 
Precise mechanism not 
completely understood. Fungal 
cell permeability changes. 
Binding to 1,3-β-glucan. 1,3-β-
glucanase activity 
Defensins Mammals, Fungi, Insects, 
Plants 
Low-molecular mass, 
cysteine-rich peptides 
Mechanisms not clearly 
elucidated. Acts on fungal 
membranes, leading to ion efflux 
Cyclophilin-like 
proteins 
Bacteria, Plants, Animals, 
Fungi 
Intracellular receptors 
for cyclosporin 
Unknown 
Ribosome-
inactivating 
proteins (RIPs) 
Fungi, Plants RNA N-glycosidases 
that depurinate RNA 
Inactivates fungal ribosomes 
Lipid Transfer 
Proteins (LTPs) 
Mammals, Plants, Fungi, 
Bacteria 
Molecular masses of 
~8.7 kDa 
Unknown 
Protease 
Inhibitors 
Plans, Animals, 
Microorganisms 
Protein inhibitors of 
serine and cystein 
protease 
Unknown 
Other proteins Plants E.g. Viridin, Snakin-1 Unknown 
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Table 2.4  Small, cysteine-rich antimicrobial peptides from plants (Lay and Anderson, 2005; 
Benko-Iseppon et al., 2010). AA denotes the number of amino acid residues and DB the 
number of disulfide bridges. 
Family Representative 
member 
AA DB Protein structure Reference 
Plant defensin Rs-AFP1 51 4 (Terras et al., 1995) 
Thionin α-purothionin 45 4 (Ohtani et al., 1977) 
Lipid Transfer 
Protein 
Ace-AMP1 93 4 (Cammue et al., 1995) 
Hevein-type Ac-AMP2 30 4 (Broekaert et al., 1992) 
Knottin-type Mj-AMP1 36 3 (Cammue et al., 1992) 
Cyclotide Kalata B1 29 3 (Jennings et al., 2001) 
Four-cysteine Ib-AMP1 20 - - (Patel et al., 1998) 
Twelve-cysteine Snakin-1 63 - - (Segura et al., 1999) 
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Perhaps the most important of these families in plants, are the plant defensins. 
The first members of the plant defensin family were isolated from wheat and barley 
grains (Colilla et al., 1990; Mendez et al., 1990). They were originally classified as a 
new subgroup of thionins and named “γ-thionins” on account of their amino acid 
sequence similarity to α- and β-thionins. Further investigation on this new class of 
thionin revealed that they, in truth, showed a low degree of structural similarity to 
thionins and it was established that thionins and γ-thionins were unrelated (Terras et 
al., 1992; Bruix et al., 1995). In 1995, Terras et al. proposed the term “plant defensin” 
be used to describe these peptides and their homologs in plants (Terras et al., 
1995).  
The term was again used in the same year by Broekaert et al. (1995) in a 
review article which suggested that plant defensins share more structural similarity 
with defensins of vertebrate and invertebrate origin than with thionins. This 
significant homology (which included the occurrence of eight Cys residues, two Gly 
residues, an aromatic residue and a Glu residue at positions resembling analogous 
conserved residues in plant defensins) suggests that plant defensins belong to a 
superfamily of antimicrobial peptides, with representatives in vertebrates, 
invertebrates and plants, indicating that these defense molecules predate the 
evolutionary divergence of animals and plants (Broekaert et al., 1995; Lay and 
Anderson, 2005; Benko-Iseppon et al., 2010). 
 
2.4.3 Mode of antifungal action of plant defensins 
Plant antifungal peptides have been shown to inhibit the growth of a broad range of 
phytopathogenic fungi and even in some cases human fungal pathogens (e.g. 
Candida albicans) at very low concentrations (Broekaert et al., 1997; Thevissen et 
al., 2004). Very few plant defensins seem to possess antibacterial activity, although 
there are exceptions, e.g. fabatin-1 and -2 (Zhang and Lewis, 1997).  
27 
Osborn et al. (1995) observed that different types of plant defensins exert 
different physiological effects when tested against Fusarium culmorum. Based on 
these observations, two groups of defensins can be distinguished. “Morphogenic” 
plant defensins are characterized by reducing hyphal elongation with a concurrent 
increase in hyphal branching in treated hyphae. “Non-morphogenic” plant defensins 
also reduced the rate of hyphal elongation, but do not bring about any marked 
morphological changes (Osborn et al., 1995). It has to be noted that this 
morphogenic/non-morphogenic effect of defensins can be dependent on both the 
test fungus and test medium and is therefore not an absolute means to classify 
defensins. 
The exact mechanism of antifungal action, whether it be morphogenic or not, 
has to date not been elucidated (Broekaert et al., 2000; Lay and Anderson, 2005; 
Portieles et al., 2006). A number of common observations regarding possible modes 
of action have been made. It has, for instance, been noticed that the antifungal 
activity of plant defensins against a test fungus is markedly reduced in the presence 
of monovalent and divalent cations in the growth medium (Broekaert et al., 1992; 
Osborn et al., 1995).  
It was also noted that the antifungal activity was slightly more reduced by Ca2+ 
than by Mg+. The same phenomenon has been observed for other small, basic, 
antimicrobial proteins, including insect and mammalian defensins (Cociancich et al., 
1993; Bals et al., 1998). It is generally accepted that plant defensins act at the level 
of the plasma membrane of the fungus, as seems to be implied by the rapid Ca2+ 
influx and K+ efflux witnessed when radish (Rs-AFP2) and dahlia (Dm-AMP1) 
defensins are added at inhibitory concentrations to the hyphae of the fungus 
Neurospora crassa (Thevissen et al., 1996; 1999).  
Fungi grow from the tip, which requires the maintenance of an intracellular Ca2+ 
concentration to drive polarized growth (Garrill et al., 1993; De Samblanx et al., 
1997). Growth inhibition caused by plant defensins may be a result of the dissipation 
of this gradient as a result of ion flux caused by the peptide (Thevissen et al., 1996). 
The clear link between ion flux and antifungal activity was illustrated by De Samblanx 
and colleagues. A variant of Rs-AFP2 with enhanced antifungal activity caused an 
increased uptake of Ca2+, while a second variant with no antifungal activity caused 
no Ca2+ uptake (De Samblanx et al., 1997). 
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Despite evidence hinting at possible modes of action, for most plant defensins, 
the molecular components involved in signaling and putative intracellular targets 
remain unknown. Only recently have research groups been able to reveal part of the 
molecular basis for antifungal activity in some plant defensins (Aerts et al., 2008). 
Dm-AMP1 (from dahlia), Rs-AFP2 (from radish) and Hs-AFP1 (from coral bells) 
were the first plant defensins to provide clues to their mode of antifungal action. Dm-
AMP1 and Rs-AFP1 inhibit fungal and yeast growth by inducing a range of rapid 
responses in fungal cells, including increased K+ efflux and Ca2+ influx, alkalinization 
of the medium and membrane potential changes (Thevissen et al., 1996). Membrane 
permeabilization by the peptides was only detected at levels around 10 times more 
than the concentration inhibiting 100% growth. It was also evident that membrane 
permeabilization only occurred 2-4 hours after initial addition of the peptides to the 
hyphae. This suggests that permeabilization of membranes by plant defensins is a 
secondary effect of their antifungal activity, rather than the cause of the observed 
ion-flux (Thevissen, 1999). 
Radiolabeled Dm-AMP1 was used to demonstrate the existence of high-affinity 
binding sites on fungal cells and membrane fractions. The binding site for Dm-AMP1 
was identified as mannosyldiinositolphosphoryl-ceramide [M(IP)2C]. Yeast mutants 
deficient in the M(IP)2C biosynthesis genes (IPT1 and SKN1) proved resistant to 
Dm-AMP1. ELISA-based binding studies also indicated that Dm-AMP1 interacts 
directly with Saccharomyces cerevisiae sphingolipids (Thevissen et al., 2000; 2003; 
2005).  
Similarly, it was revealed that yeast mutants deficient in the glucosylceramide 
(GlcCer) biosynthesis gene GCS1, are resistant to Rs-AFP2 (Thevissen et al., 2004). 
This occurrence lends itself to explain the inherent resistance of S. cerevisiae and C. 
glabrata to Rs-AFP1, since they naturally lack GlcCer in their membranes. Through 
ELISA-based binding assays, it was shown that while Rs-AFP2 interacts with GlcCer 
isolated from Pichia pistoris, it fails to react with GlcCer from soybean or human 
membranes (Thevissen et al., 2004). This seems to account for non-toxicity of Rs-
AFP1 to plant and human cells. 
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MsDef1 (previously named AlfAFP) is a broad-spectrum antifungal defensin 
from alfalfa (Medicago sativa) seeds. MsDef1 inhibits fungal elongation of Fusarium 
graminearum whilst causing a hyperbranching phenotype (Spelbrink et al., 2004). It 
is known that hyphal elongation is controlled by a gradient of cytosolic Ca2+. 
Disruption of this gradient is known to cause hyperbranching (Tsien and Tsien, 
1990). These observations gave rise to the hypothesis that MsDef1 blocks Ca2+ 
channels, thereby causing hyphal growth defects. The suggestion that certain 
antifungal peptides inhibit fungal growth through the blocking of Ca2+ channels is 
supported by studies demonstrating that fungal elongation is a complex process 
which relies heavily upon a maintained calcium gradient (Shaw and Hoch, 2001).  
A more recent theory is that plant antifungal peptides exert their antimicrobial 
activity not only through membrane-related actions, but also through cytoplasmic 
targets (Xiong et al., 1999; Aerts et al., 2008; López-García et al., 2010). Psd1 
defensin (from Pisum sativum) increased the DNA content of conidial cells without 
subsequent completion of cell-division. This proposes that Psd1 affects the normal 
progression of the cell cycle (Lobo et al., 2007). 
Recent studies have therefore suggested that the mode of action of antifungal 
peptides extend beyond cell lysis and membrane permeabilization and that 
additional mechanisms are at play (Amien et al., 2010; López-García et al., 2010). 
The role of the cell wall in AMP mode of action is also being investigated. López-
García et al. (2010) tested two unrelated AMPs against S. cerevisiae to examine the 
antifungal effect of the peptides. They showed that a weakened cell wall does not 
necessarily lead to a higher sensitivity to an AMP (López-García et al., 2010) 
suggesting that the cell wall itself may have a role in the AMP mode of action.  
Similarly, Amien et al. (2010) showed that permeabilization of fungal hyphae by the 
plant defensin NaD1 also involves a process that may be cell wall-dependent. Fungi 
with compromised cell walls were treated with NaD1, but the peptide showed a 
decrease in potency. This indicates that the peptide may interact with a 
proteinaceous receptor found on the cell wall itself. 
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2.4.4 Developmental role of antimicrobial peptides 
Antimicrobial peptides are clearly an integral part of innate immunity in plants, 
insects and mammals. Most studies focus on the characterization of the in vitro 
antimicrobial activity of these peptides, or deciphering their modes of action. A third, 
non-defense role of these peptides is becoming clear. It has been suggested that 
many of these peptides have a definite role in developmental regulation of the 
tissues they are native to. This phenomenon has been observed in both mammalian 
and plant peptides. 
A β-defensin named Bin1b is a rat epididymis-specific peptide (with a 
homologue found in humans). Bin1b is both structurally and with regards to 
antimicrobial activity similar to β-defensins. The region-specific expression of this 
peptide led researchers to investigate a possible role in sperm maturation. It was 
concluded that not only does Bin1b kill bacteria, it also plays a role in the maturation 
of sperm in the epididymis (Zhou et al., 2004). 
DEF2, a defensin isolated from tomato, shows strong antifungal activity against 
Botrytis cinerea. The peptide is expressed during early flower development, and 
initial sense and antisense expression studies seem to indicate the peptide has a 
role in  development and pollen viability (Stotz et al., 2009).  
Allen et al. (2008) investigated the effects of plant defensins MsDef1, MtDef2, 
RsAFP2 and fungal toxin KP4 on plant root growth. They showed that all four 
peptides block root growth in a reversible manner, but that the inhibitory activity on 
the plant root was not directly correlated with the antifungal activity of the peptides. 
They suggest that these plant defensins have regulatory roles in plant development 
and growth (Allen et al., 2008). In maize, a cysteine-rich defensin-like peptide 
(ZmES4) was shown to induce pollen-burst in a species-specific manner (Amien et 
al., 2010).   
Most antimicrobial peptides and defensins are developmentally regulated and 
are often expressed in a tissue-specific manner. This supports the possibility that 
these peptides serve dual roles, both as regulators of development and growth as 
well as antimicrobial action. As with the mode of action, there is still much research 
to be done to further investigate the importance of these peptides as having 
developmental roles. 
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2.5 AMPs and grapevine 
Modern viticulture faces a number of challenges to maintain sustainable production 
of high quality grapes in a changing environment. Meeting these challenges requires 
an extensive understanding of the genetics and biology of the grapevine (Vitis 
vinifera L.), as well as interactions with its environment in the vineyard (Martìnez-
Zapater et al., 2009). The potential of grapevine as a model organism for fruit trees 
has made it an important focal point for research on a genomics level, matching 
advances made with sequenced Arabidopsis, rice and poplar genomes (Troggio et 
al., 2008). The amount of genetic information available for grapevine has increased 
dramatically during the past decade (Troggio et al., 2008), including SNP-based 
markers (NCBI, http://www.ncbi.nlm.nih.gov), genetic maps constructed based on 
these markers (Troggio et al., 2007), the identification of quantitative trait loci (QTLs) 
for various traits (Xu et al., 2008), expressed sequence tags (ESTs) (da Silva et al., 
2005; Moser et al., 2005; Peng et al., 2007) and associated proteomic and metabolic 
profiles (Sarry et al., 2004; Castro et al., 2005; Mattivi et al., 2006; Deluc et al., 2007; 
Deytieux et al., 2007; Young and Vivier, 2010). 
The importance of grapevine and the scientific focus on this woody perennial 
have motivated the sequencing of the V. vinifera genome (Jaillon et al., 2007; 
Velasco et al., 2007). The availability of the genome sequence as well as rapidly 
evolving DNA techniques and technologies are providing tools that promise to 
revolutionize grapevine breeding techniques and support to grapevine research. 
Sequencing projects have provided researchers with information previously only 
available for model plant systems (Di Gaspero and Cattonaro, 2010).  
This wealth of genomic information has made bioinformatics-coupled molecular 
approaches to gene discovery and the “mining” for potential genes of interest 
accessible to all researchers. Completed genomes sequences are available for a 
number of crop plants, including papaya (Carica papaya), maize (Zea mays), rice 
(Oryza sativa), apple (Malus domestica) and grapevine (V. vinifera) and these 
genomes are available on different databases that are publicly available (Table 5). 
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Table 2.5 Summary of publicly available databases providing searchable whole genome 
sequences (including crop plants). 
Database Website (http://) Organisms No. of 
available 
genomes 
NCBI http://www.ncbi.nlm.nih.gov/sites/genome Prokaryotes, 
Eukaryotes 
832 
Plaza http://bioinformatics.psb.ugent.be/plaza/ Plant 23 
Genoscope http://www.genoscope.cns.fr Prokaryotes, 
Eukaryotes 
8 
IASMA http://genomics.research.iasma.it/ Plant 2 
Genome 
Database for 
Rosaceae (GDR) 
http://www.rosaceae.org/ Plant 9 
The availability of these databases facilitates the use of a number of 
bioinformatics tools for in silico screening for genes of interest, such as antimicrobial 
peptides. Plant peptides comprise almost 16% of all available AMP sequences in 
publicly available databases, including lipid transfer proteins, snakins, heveins, 
thionins and defensins. A simple search on any one of these databases will provide 
a number of both annotated and putative AMP-related sequences from plants (Clara 
Pestana-Calsa et al., 2010).  
The publication of the complete V. vinifera genome, access to extensive EST 
databases and the availability of a variety bioinformatics tools and software has 
made it possible to screen the grapevine genome in silico for potentially new 
antimicrobial peptides. 
Using sequences of known antimicrobial peptides, the V. vinifera genome can 
be screened for similar sequences. These sequences can further be investigated by 
searching for available EST data linked to the sequences. They can also be 
compared to other, similar peptides through amino acid alignment analysis. Putative 
antimicrobial peptides will show sequence and structure similarity to known 
antimicrobial peptides. This approach will undoubtedly become the first step in most 
antifungal peptide studies of plants with sequences genomes. 
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2.5.1 The isolation and characterization of the first grapevine defensin: Vv-
AMP1 
Through extensive analysis of sequence databases for novel plant defenses, a 
putative plant defensin encoding gene was identified in V. vinifera (De Beer, 2008; 
De Beer and Vivier, 2008). The gene was designated Vitis vinifera antimicrobial 
peptide 1 (Vv-AMP1). Analysis of the then recently released V. vinifera genome 
indicated the gene is present as a single copy on chromosome 1. 
The size of the Vv-AMP1 coding sequence was shown to be 234 bp, and the 
gene encodes a predicted 77 amino acid peptide. This peptide comprises of a 30 
amino acid signal peptide and a 47 amino acid mature peptide. The genomic copy of 
the gene is 742 bp in size. Comparison with the cDNA sequences indicates the 
presence of a 508 bp intron interrupting the predicted signal peptide. 
Alignment analysis indicated a high sequence homology on amino acid level to 
γ-thionins and comparative homology modeling of the deduced amino acid sequence 
revealed that the tertiary structure of Vv-AMP1 showed the typical defensin structure 
consisting of an α-helix and triple-stranded anti-parallel β-sheet, stabilized by 
disulfide linkages between eight cysteine residues. 
The expression profile of Vv-AMP1 revealed that the gene is expressed in a 
tissue-specific manner, with expression only detected in berries. Gene expression is 
also highly developmentally regulated, with expression induced upon berry ripening 
(specifically at the onset of berry ripening, or véraison, 11 weeks post-flowering). 
Expression levels remained high throughout the remaining berry ripening stages. 
Induction studies (via wounding, osmotic stress, infection stress and treatment with 
jasmonic-, salicylic- and abscisic acid) were unable to induce Vv-AMP1 expression, 
either in leaf material or pre- véraison berries (De Beer and Vivier, 2008).  
Sequence analysis predicted that the grapevine plant defensin would be 
localized to the apoplastic regions of plant tissues. Localization studies were carried 
out by fusing the Vv-AMP1 signal peptide to the green fluorescent protein GFP and 
constitutively overexpressed the fusion peptide in tobacco. Through fluorescent 
microscopy, it was confirmed that the signal peptide targeted the reporter gene to the 
apoplast (De Beer and Vivier, 2008), thereby confirming an apoplastic localization for 
Vv-AMP1. 
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Vv-AMP1, fused to a GST-tag, was recombinantly produced in E. coli using the 
Rosetta Gami pLysS expression system and glutathione affinity chromatography. 
Through mass spectrometry, the size of the recombinant peptide was determined to 
be 5,495 kDa. The antimicrobial activity of recombinantly produced Vv-AMP1 was 
tested against several pathogenic plant fungi using a dose-response growth 
inhibition assay (Broekaert et al., 1990). The peptide showed activity against a range 
of fungi, including F. oxysporum and V. dahlia with IC50 values of 6 µg/ml and 1.8 
µg/ml respectively (De Beer and Vivier, 2008).  
Microscopical analysis of treated fungal hyphae showed no signs of 
hyperbranching, though the ability of the hyphae to elongate was severely affected 
by the peptide. The peptide was thus categorized as a non-morphogenic peptide. A 
propidium iodide uptake assay showed that untreated fungi showed no fluorescence 
while treated samples showed high levels of fluorescence. This indicated the fungal 
membranes were compromised in the presence of Vv-AMP1 (De Beer and Vivier, 
2008). 
Despite the activity of the Vv-AMP1 peptide against a number of fungal 
pathogens, the overexpression of Vv-AMP1 in tobacco did not reduce disease 
susceptibility towards B. cinerea. This could be attributed to either post-
transcriptional modification of the Vv-AMP1 peptide or the instability of the peptide in 
the tobacco apoplast. With Vv-AMP1 expression being so tightly regulated in its 
native host, V. vinifera, it has been suggested that the stability of the peptide is 
dependent on specific physiological conditions only present in the grapevine berries 
at the onset of berry ripening (De Beer, 2008; De Beer and Vivier, 2008). 
Further investigation regarding the characteristics and function of this peptide, 
including evaluating the role of the peptide within its native host, as well as its 
effectiveness against typical grapevine fungal pathogens are still required and 
formed the base of this thesis (see Chapter 4). 
2.6 Summary 
Our knowledge and understanding of host defense systems has rapidly expanded 
over the past decade. The importance of antimicrobial peptides in host defense has 
become clear and the potential of these peptides have become the focus of 
biotechnological research, for both clinical and agricultural purposes.  
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Antimicrobial peptides have been isolated from diverse groups of organisms, 
including invertebrates, vertebrates, insects and plants. These peptides are 
classified into different categories based on their size, conformational structure and 
amino acid composition. Of all the antimicrobial peptides isolated in plants, the 
majority are typically plant defensins.  
The exact mechanism of antifungal action of plant defensins is not entirely 
understood, but it is generally accepted that the peptides act on the fungus at the 
level of the plasma membrane. It has also been shown that some defensins such as 
NaD1 require interaction with the fungal cell wall in order to permeabilize the plasma 
membrane. This suggests that NaD1 permeabilizes the cell membrane in a novel 
way, utilizing a receptor which is possibly located in the proteinaceous layer of the 
cell wall (van der Weerden et al., 2010). Other studies suggest that many defensins 
exhibit a dual role in general plant development.  
With the rapid increase in available genome sequences for plants and other 
organisms, as well as extensive databases for ESTs and antimicrobial peptides, the 
discovery of novel antimicrobial peptides has not only increased exponentially, but 
allowed for more targeted approaches.  
One such discovery was the first antimicrobial peptide in grapevine, Vv-AMP1, 
(with the possibility of several more AMPs of different classes found in the genome). 
The discovery, isolation and characterization of Vv-AMP1 have enabled further 
investigation of the biological role of the peptide within its native host.  
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3.1 Abstract 
Antimicrobial peptides occur in many living organisms and isolation, characterization 
and functional analyses of a wide spectrum of these peptides have confirmed their 
importance in defense systems of their respective hosts. The recombinant 
production of antimicrobial peptides in heterologous expression systems presents a 
multitude of obstacles and often requires fusing the mature peptide to a tag-protein 
to prevent the peptide from showing activity during production. Here we report on the 
recombinant production of Vv-AMP1, a defensin peptide previously isolated from 
grapevine. We show that with specific optimization we could improve the yield of 
mature Vv-AMP1 significantly by systematically evaluating and optimizing several 
steps of the induction and purification procedure. The optimized purification method 
yielded up to 3 mg of pure Vv-AMP1 peptide from 1.6 L of an overnight culture. The 
identity and integrity of the peptide was confirmed through SDS-PAGE and Western 
blot analysis. However, the recombinantly produced Vv-AMP1 was inactive against 
two test organisms known to be very sensitive to Vv-AMP1. Previous in vitro studies 
confirmed activity of Vv-AMP1 against Botrytis cinerea at very low concentrations, 
but the bacterially produced Vv-AMP1 did not show any activity against this 
organism in liquid plate assays, even at excessively high concentrations. The results 
suggest that an important aspect for peptide activity such as folding, or perhaps 
specific co-factors are not supported in the non-host prokaryotic production system 
used in this study. 
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3.2 Introduction 
Antimicrobial peptides are biologically active molecules that form part of host 
immunity. They have been identified and isolated from a variety of sources, including 
mammals, plants, insects, amphibians, fish and prokaryotes (Andreu and Rivas, 
1998; Hancock and Lehrer, 1998; Izadpanah and Gallo, 2005). These peptides often 
have a broad range of activity against bacteria and fungi, while having minimal toxic 
effect on the host (Lehrer et al., 1993; Rao, 1995; Reddy et al., 2004). Their potent 
anti-pathogenic characteristics make them promising targets for research in the 
pharmaceutical, medical and crop biotechnology sectors.  
 Current methods of peptide production are generally limited and often production 
yields are very low whereas large quantities of peptide are required to evaluate the 
characteristics of the peptides. Small peptides can be efficiently produced through 
chemical synthesis, but this requires specific expertise and equipment (Bruckdorfer 
et al., 2004). Small, cysteine-rich peptides such as defensins often occur in 
multigene families. Their conserved structural features make it difficult to purify a 
specific peptide from a pool of very similar peptides found in the source organs or 
species (Ingham and Moore, 2007). If the sequence of the peptide is known, 
heterologous production can facilitate the production of a specific peptide. 
Recombinant methods allow the production of peptides in expression systems 
such as yeast or bacteria (Zorko et al., 2009). With the field of peptidomics 
expanding rapidly, the demand for efficient, relatively simple methods of recombinant 
protein production has increased greatly in recent years (Terpe, 2003).  
 A well developed method of recombinant protein production typically involves 
the use of affinity-tags (Makrides, 1996). The basic features of affinity-tag systems 
include the fusion of an affinity-tag to the target peptide, simple adsorption 
purification, easy and specific removal of the affinity-tag and straightforward recovery 
of the purified peptide. A variety of affinity-tag systems are commercially available, 
including polyarginine-tags (Arg-tag), polyhistidine tags (His-tag), Strep-tag, 
calmodulin-binding peptide (CBP), maltose-binding protein (MBP) and glutathione S-
transferase (GST) tags (Terpe, 2003). 
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Affinity-tag purification, however, often affects important characteristics or 
functions of the protein or peptide it is fused to. Removal of the tag is generally 
necessary and achieved through cleaving with a site-specific protease such as 
thrombin, enterokinase or Factor Xa (Ingham and Moore, 2007). Other systems rely 
on intein-mediated purification, which allows cleavage of the tag without protease 
activity, but rather through a self-splicing intein (Morassutti et al., 2002; Sharma et 
al., 2006). 
The expression of antimicrobial peptides in microbial systems poses some 
difficulties, the most apparent being the potential cytotoxicity of the produced active 
peptide to the host cells (Jin et al., 2006; Xu et al., 2007). Recombinant production of 
these peptides is made possible by using affinity-tag systems. The fusion of the 
antimicrobial peptide to a partner- or tag-protein renders the peptide inactive, 
allowing production with no toxic effects to the host cells (Wei et al., 2005). Once the 
peptide is released from the fusion protein through chemical or enzymatic cleavage, 
it should regain its activity (Ingham and Moore, 2007).  
Despite the development and improvement of these recombinant peptide 
production systems, producing and purifying of antimicrobial peptides still present a 
number of challenges. Extensive knowledge and understanding of the target protein 
or peptide is required to individually optimize each step in the production process. 
Working with small peptides is often difficult, demanding stable, controlled and highly 
repeatable conditions. Simple, technical aspects related to the type of material used, 
the preparation of the consumables and even the environmental conditions during 
the experiment could have an influence on peptide production, yield and even 
stability. 
Previously, the first grapevine defensins, Vv-AMP1, was isolated, purified and 
characterized. In vitro assays indicated it was a non-morphogenic peptide which was 
able to disrupt the membranes of fungal pathogens (De Beer and Vivier, 2008). 
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In this previous study, Vv-AMP1 was overexpressed and purified in an active 
form using the pGEX bacterial overexpression system, but relatively low yields were 
obtained (De Beer and Vivier, 2008). The aim here was to systematically optimize 
induction and purification to increase yields of active Vv-AMP1 peptide to use in 
activity assays against a range of grapevine pathogens. A consistent method of 
production of Vv-AMP1 was undertaken through a number of optimization steps 
(outlined in Table 3.1), but despite having increased yields, the peptide produced 
was not active against organisms known to be sensitive against Vv-AMP1. The 
results suggest that the optimized production system negatively impacted on a 
crucial aspect required for activity of this peptide. 
3.3 Materials and Methods 
3.3.1 Microbial and fungal pathogen strains 
For recombinant protein production, Escherichia coli strain BL21 (Rosetta-gami pLys 
S) DE3 (Novagen (Madison, WI, USA) was used. Cultures were maintained as 
freeze cultures containing 50% (v/v) glycerol and stored at -80°C. Botrytis cinerea 
was obtained from the Institute for Wine Biotechnology (IWBT). Cultures were 
maintained on sterile apricot halves in corning tissue culture plates at 25°C until 
sporulation. Spores were harvested in sterile dH2O, 24 h prior to use and hydrated 
overnight at 4°C. 
 
3.3.2 Transformation of E. coli with GST expression vector 
The pGEX-2T system (Amersham Biosciences, NJ, USA) was used for the 
recombinant production of Vv-AMP1 in E. coli. The system would produce mature 
Vv-AMP1 peptide fused to the GST-tag. The pGEX-Vv1 expression vector was 
constructed as described in De Beer and Vivier (2008). The integrity of the construct 
was verified through sequencing (Central Analytical Facility, University of 
Stellenbosch) and the construct was found to contain the correct sequence of the 
Vv-AMP1 gene. 
The confirmed pGEX-Vv1 vector was transformed into the BL21 strain of E. coli 
using a heat shock transformation method. 50 ng of pGEX-Vv1 DNA was added to a 
100 μl aliquot of BL21 cells. The mixture was incubated on ice for 1 h. Thereafter it 
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was heat shocked for 45 s at 37ºC and incubated on ice for 2 min. 1 ml LB liquid 
medium (Merck, NJ, USA) without antibiotics was added and mixture was incubated 
at 37ºC for 60 minutes.  
Cells were plated out on selective media of LB agar containing 50 g.ml-1 
ampicillin, 34 g.ml-1 chloramphenicol (Roche Diagnostics GmbH, Mannheim, 
Germany), 12.5 g.ml-1 tetracyclin and 15 g.ml-1 kanamycin sulphate (Sigma, St. 
Louis, USA) and. Plates were incubated overnight at 37ºC. Positive colonies were 
picked, inoculated in selective liquid media and incubated overnight at 37ºC. Freeze 
cultures were made by adding 1 ml of overnight culture to 1 ml 80% (v/v) glycerol. 
Freeze cultures were stored away at -80ºC. 
 
3.3.3 Standard method of recombinant production and purification of Vv-
AMP1 
The standard method of recombinant production and purification of Vv-AMP1 was 
followed as described by De Beer and Vivier (2008). This method was used for 
comparison with the optimized induction and production method (see section 3.3.4). 
 
3.3.4 Optimized induction, production and purification of Vv-AMP1 
Growth conditions and other basic steps were followed as described by De Beer and 
Vivier (2008). The specific optimizations refined for Vv-AMP1 production are 
summarized in Table 1. 
5 ml LB growth medium containing antibiotics (50 g.ml-1 ampicillin, 12.5 g.ml-
1 tetracyclin, 15 g.ml-1 kanamycin sulphate and 34 g.ml-1 chloramphenicol) was 
inoculated from a freeze culture of E. coli BL21 containing the pGEX-Vv1 construct 
and grown overnight at 37°C. One ml preculture was inoculated into four 1 L 
Erlenmeyer flasks, each containing 400 ml of LB growth medium with antibiotics. The 
cultures were grown at 37°C with continuous shaking until an OD600 of 0.7 was 
reached.  Expression of the GST-VvAMP1 fusion peptide was induced with 0.4 mM 
of Isopropyl β-D-1-thiogalactopyranoside (IPTG) (Roche Diagnostics GmbH, 
Mannheim, Germany) for 5 hours at room temperature. Bacterial pellets were 
harvested by centrifugation (10 min, 5000 x g 4°C); pellets were resuspended in 10 
ml GST binding buffer (300 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4) 
and frozen at -80°C. Cells were disrupted through 6-8 repetitive freeze-thaw cycles 
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from liquid nitrogen to a 37°C waterbath. 5 mM MgCl2 was added to and lysate was 
treated with 10 units of DNase I (Roche Diagnostics GmbH, Mannheim, Germany) 
for 15 minutes at room temperature to reduce viscosity. Triton x-100 was added to a 
final concentration of 1% (w/v). Lysate was centrifuged at 10 000 rpm for 15 minutes, 
clear lysate was removed and passed through a 0.22 µM filter. 
 
Table 3.1. Systematic optimization steps undertaken to improve production and purification 
of Vv-AMP1 from the pGEX bacterial overexpression system. 
Steps in the 
overproduction and 
purification procedure 
targeted for optimizations 
Aspects evaluated Parameter optimized 
Induction of peptide 
production by the bacterial 
culture 
Optimal conditions and 
length of induction with 
IPTG 
Induction temperature (37°C 
versus room temperature) 
and induction time (overnight 
versus 5 hours) 
Purification Preparation and binding of 
lysate 
Composition of binding buffer 
(135 mM versus 300 mM) 
Shorter binding time 
(overnight versus 1 hour) 
 Washing of column Optimal wash volume (5 
column volumes versus 10 
column volumes) 
 Elution Concentration of reduced 
glutathione (10 mM versus 
50 mM) 
 Thrombin cleavage Efficiency of different 
enzymes (Novagen thrombin 
protease versus Amersham 
thrombin protease) 
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Prepared lysate was added to a 2 ml bed volume of Glutathione agarose 4B 
(Sigma, St Louis, USA). Recombinant peptide was allowed to bind to the agarose for 
4 hours on a rotor mixer. Unbound proteins were removed by washing the column 
twice times with 10 ml GST wash buffer (50 mM Tris-HCl pH 7.5, 0.25 mM NaCl, 2 
mM EDTA) and once with 10 ml GST wash buffer containing 1% Triton x-100 to 
remove unspecific proteins. Bound recombinant GST-VvAMP1 peptide was eluted 
with 15 ml elution buffer (50 mM Tris-HCl, pH 8.0, 50 mM reduced glutathione). The 
N-terminal GST tag was removed with 20 units of thrombin protease enzyme 
(Amersham Biosciences, NJ, USA) digested overnight at room temperature. 
 
3.3.5 Size determination, identification and immunoblotting of heterologously 
produced Vv-AMP1 
Confirmation of Vv-AMP-GST fusion proteins and evaluation of cleavage of Vv-
AMP1 from the GST-tag were achieved through separation on a 15% [w/v] tricine-
sodium dodecyl sulfate-polyacrylamide gel (Schägger & von Jagow, 1987). After 
separation, the gels were microwaved in a staining solution (Coomassie R250 
dissolved in 50% [v/v] ethanol and 10% [v/v] acetic acid) until the solution boiled. 
Thereafter, gels were placed on a shaker for 30-60 minutes. After sufficient staining, 
the gels were placed in a destaining solution (12.5% [v/v] isopropanol and 12% [v/v] 
acetic acid) until the background was removed and the bands were clearly visible.  
Western blot analyses were conducted on samples of putatively purified Vv-
AMP1. A sample of confirmed purified Vv-AMP1 peptide (obtained from Dr. A. De 
Beer) was always present as a positive control. The samples and a low molecular 
weight marker (Sigma, St Louis, USA) were separated on a 15% (w/v) Tricine-SDS-
PAGE (Schägger & von Jagow, 1987). The membrane was electroblotted to PVDF 
membranes (BioRad, Hercules, CA, USA) for 30-60 minutes (400 V, 75 mA). 
Membranes were carefully removed from the electroblotting apparatus and placed in 
blocking reagent (5% skim milk powder dissolved in Tris-buffered saline and 0.1% 
[w/v] Tween 20) for 1 hour, at room temperature. Membranes were rinsed with 2 
changes of wash buffer (0.1 % [w/v] Tween 20 in Tris-buffered saline) before being 
incubated for 1 hour in a 1:5000 dilution of primary antibody prepared in blocking 
buffer. Primary antibodies (obtained from Dr. A. De Beer) were polyclonal antibodies, 
produced in mice against the GST-VvAMP1 fusion protein. Membranes were rinsed 
for 15 minutes in wash buffer, followed by three 5-minute washes. Thereafter the 
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membranes were incubated for 1 hour with anti-mouse IgG secondary antibody 
(Sigma, St Louis, USA). Membrane wash steps were repeated as described. The 
wash buffer was discarded and detection of Vv-AMP1 was completed using the ECL 
chemiluminescent system according to Amersham Biosciences, NJ, USA.  
 
3.3.6 Antimicrobial activity of recombinant Vv-AMP1 
The quantitative antifungal activity of the antifungal peptides was measured using a 
microspectrophotometric antifungal assay (Broekaert et al., 1990). The assay was 
performed in a 96 well microtiter plate (Nunc). Each individual reaction contained 
100 µl half strength potato dextrose broth (Merck, NJ, USA) with 2000 fungal spores 
and a range of peptide concentrations. The control wells contained no peptide. The 
plates were incubated in the dark at 25°C for 2 days. Microspectrophotometric 
readings were taken every 24 hours at 595 nm (PowerwaveX microplate reader, 
Bio-Tek instruments inc.). 
Measurements (A595) were taken at 0 h, 24 h and 48 h. Values were corrected 
by subtracting the 0 h value from the 24 h and 48 h measurements. Activity is 
expressed in terms of the percentage growth inhibition and can be calculated with 
the formula: 
 



  100
)(
)()(
100%
595
595595
CONTROL
SAMPLECONTROL
ACorrected
ACorrectedACorrectedInhibition
 
  
58 
3.4 Results 
3.4.1 Induction of peptide production 
Induction of the bacterial culture to initiate production of the recombinant GST-
VvAMP1 peptide was achieved through addition of IPTG. Preliminary experiments 
indicated that the level of production of the fusion peptide was directly affected by 
both temperature and length of induction (results not shown). Yields were improved 
by a lower induction temperature and shorter induction times (results not shown). 
Optimal induction conditions proved to be at room temperature for 5 hours on an 
orbital shaker (Figure 3.1). Figure 3.1(B) shows an increased production of the 
fusion peptide (~31 kDa) under optimized conditions when compared to the standard 
method (overnight at 37ºC). 
 
Figure 3.1 SDS-PAGE analysis comparing recombinant protein production between 
standard (A) and optimized (B) methods. In panel A: Lane M – 5 µl PageRuler ™ prestained 
protein ladder (Fermentas); Lane 1 – 5 µl of sample induced overnight at 37°C ; In panel B: 
Lane M – 5 µl PageRuler ™ prestained protein ladder (Fermentas); Lane 1 – 5 µl of sample 
before induction; Lane 2 - 5 µl of sample induced at room temperature for 5 hours. 
 
3.4.2. Purification 
Subsequent purification steps to isolate the fusion peptide and to separate Vv-AMP1 
from the GST-tag and the protease required optimization at a number of stages (see 
  M                 1  M            1               2     
~31 kDa 
~31 kDa 
A B 
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Table 1). Binding of the lysate to the affinity column was improved by increasing the 
concentration of salt in the buffer from 135 mM to 300 mM (results not shown). This 
reduced the amount of non-specific proteins binding to the Sepharose 4B column. 
Overnight binding of the lysate to the column proved excessive as 1 hour of binding 
proved sufficient to bind all the GST-VvAMP1 peptide to the column. In Figure 
3.2(A), lane 2 represents a sample of the flow-through after overnight binding of the 
lysate to the Sepharose 4B column. Figure 3.2(B), lane 3 represents a sample of 
flowthrough after binding of the lysate to the column for only 1 hour. The SDS-PAGE 
analysis of the sample indicates that all the produced fusion peptide is sufficiently 
bound to the column within 1 hour.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 SDS-PAGE analysis comparing different binding conditions, wash volumes and 
elution conditions. In panel A: Lane M – prestained protein ladder (Fermentas); Lane 1 – 5 µl 
sample of lysate (post-induction) before binding to Sepharose 4B; Lane 2 – 5 µl sample of 
flowthrough after overnight binding to Sepharose 4B; Lane 3 – 10 µl sample of flowthrough 
after overnight binding to Sepharose 4B; Lane 4 and 5 - samples of column wash; Lanes 6-8 
– fractions of elution with reduced glutathione. In panel B: Lane M – prestained protein 
ladder (Fermentas); Lane 1 – 5 µl sample of lysate before induction with IPTG; Lane 2 – 5 µl 
sample of lysate (post-induction) before binding to Sepharose 4B; Lane 3 – ample of 
flowthrough after binding to Sepharose 4B column (1 h binding time); Lane 4 and 5 – 5 µl of 
consecutive samples of column wash flow-through; Lanes 6-9 – fractions of elution with 
reduced glutathione. 
~31 kDa  
~31 kDa 
M    1       2       3     4       5     6      7      8     9M       1      2       3      4       5      6      7    8 
~31 kDa  
A B 
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Washing the column to remove unbound proteins and other impurities was 
improved by increasing the wash volume from 5 column volumes to 10 column 
volumes. In Figure 3.2(A), lane 4 contains a sample of the column wash flowthrough 
using 5 column volumes of wash buffer. Lane 5 contains a sample of flowthrough 
after an additional column volume of wash buffer was added to the column. This 
sample still contained traces of non-specific proteins. In Figure 3.2(B), lane 4 
represents the sample of column wash flowthrough using 10 column volumes of 
wash buffer. Lane 5 represents a sample of flowthrough after an additional column 
volume of wash buffer was added to the column. This lane contains no detectable 
non-specific proteins. 
Elution of the GST-VvAMP1 fusion peptide from the Sepharose 4B affinity 
column was achieved by adding 10 mM reduced glutathione to the elution buffer; 
however initial glutathione elutions were unsuccessful, yielding little or no fusion 
peptide in the elution fractions. In Figure 3.2(A), the elution fractions (lanes 6-8) 
contain no eluted GST-VvAMP1 peptide when eluted with 10 mM of reduced 
glutathione. Increasing the reduced glutathione to 50 mM proved successful (Figure 
3.2(B), lanes 6-9). 
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Figure 3.3 Western blot analyses indicating the presence of GST-VvAMP1 after production 
and elution, comparing the cleaving efficiency of thrombin protease enzyme from Novagen 
and Amersham. In panel A: Lane 1 - sample of flowthrough after induction with IPTG, before 
binding to Sepharose 4B; Lane 2 - sample of flowthrough after binding to Sepharose 4B; 
Lanes 3-7 – elution fractions containing GST-VvAMP1 fusion peptide (~31 kDa) and no 
cleaved Vv-AMP1 after overnight digestion with Novagen thrombin protease. In panel B: 
Lane M – prestained protein ladder (Fermentas); Lane 1 – sample containing undigested 
GST-VvAMP1; Lanes 2-5 – elution fractions containing GST-VvAMP1 fusion peptide, GST 
and cleaved Vv-AMP1 after digestion with Amersham thrombin protease; Lane 6 – purified 
Vv-AMP1 as positive control. 
  
 
~31kDa  
~26kDa 
~5kDa 
~31kDa 
A B 
M       1        2         3       4       5                6     1       2      3      4     5        6      7
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The presence of the GST-VvAMP1 fusion peptides (~31 kDa) in the elution 
fractions were confirmed through Western blot analyses. The fusion peptide was 
present as a clear band of approximately 31 kDa in size (Figures 3.3 A and B). In 
Figure 3.3(A), lanes 1 and 2 represent samples of the lysate before and after binding 
to the column, respectively. A large ~31 kDa band is clearly visible in the sample in 
lane 1, while the band is much less pronounced in lane 2, indicating the removal of a 
large amount of the GST-VvAMP1 fusion peptide from the sample through binding to 
the column. Binding of the fusion peptide is limited by the binding capacity of the 
Sepharose 4B column. Lanes 3 to 7 indicate the presence of the fusion peptide in 
the elution fractions collected. 
Thrombin cleavage was evaluated using enzymes acquired from both Novagen 
and Amersham. Cleavage using both enzymes was attempted using 20 units of 
enzyme in 1 x PBS buffer for 16 - 22 hours at room temperature. The thrombin from 
Amersham proved far more efficient in cleaving the Vv-AMP1 from the GST-tag 
(Figure 3.3 B, lanes 2-5), though still only partially. 
Separation of the GST-tag from Vv-AMP1 through size exclusion 
chromatography on a Sephadex G-25 column clearly indicated the Vv-AMP1 peptide 
co-eluting with a salt fraction (Figure 3.4) when samples are digested in 1 x PBS. 
Desalting can be achieved using C8 columns, but this caused a notable decrease in 
peptide yield (results not shown). Alternatively, thrombin digestion in sodium acetate 
buffer (a volatile salt) allowed the addition of 100% acetonitrile to the sample, which 
facilitates removal of the GST-tag through denaturation. The sodium acetate can be 
easily removed through several cycles of freeze-drying. Concentration 
determinations revealed that up to 3 mg/ml of pure Vv-AMP1 peptide could be 
produced from 1.6 L of starting culture using this method. 
Purified putative Vv-AMP1 was tested against B. cinerea at a range of 
concentrations, from 10 µg/ml to 25 µg/ml. No significant antimicrobial activity was 
observed (Figure 3.5). Previously, 50% inhibition of B. cinerea growth was achieved 
in the presence of 13 µg/ml of purified Vv-AMP1 (De Beer and Vivier, 2008).  
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Figure 3.4 Chromatogram indicating co-elution of Vv-AMP1 fraction with salt during 
seperation through size exclusion chromatography on Sephadex G-25 (BioRad Biologic LP 
chromatography system). The blue line represents the UV measurement (measured in 
Absorbance Units) indicating the elution of the peptide off the Sephadex G-25 column. The 
pink line represents measured conductivity (mS/cm) indicating the presence of salt in the 
fraction. The chromatogram shows the overlapping of the two peaks, indicating the co-
elution of the peptide with salt. 
 
Figure 3.5 Antifungal assay evaluating the ability of purified Vv-AMP1 to inhibit the growth of 
the grapevine pathogen Botrytis cinerea at different concentrations over a period of 24 
hours. Results show no significant inhibition of fungal growth, even in the presence of 
extremely high concentrations of the putative Vv-AMP1 peptide. 
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3.5 Discussion 
The production of biologically active antimicrobial peptides are always challenging 
when using microbial production systems (Ingham and Moore, 2007). E. coli is often 
the preferred host organism for a recombinant protein production system as it offers 
several advantages: E. coli is genetically very well characterized and understood, 
with many tools available to facilitate genetic engineering through gene cloning and 
expression. Despite the extensive knowledge of this Gram-negative bacterium, there 
can be no guarantee that every gene will be successfully expressed within an E. coli 
expression system (Makrides, 1996; Schumann and Ferreira, 2004). Failure of 
recombinantly produced proteins to be effectively produced or to be biologically 
active can be attributed to factors such as incorrect folding, proteolytic degradation 
or associations with each other forming inclusion bodies (Baneyx and Mujacic, 
2004).  
The efficiency of such recombinant protein production systems are evaluated 
by considering factors such as speed of production, yield, purity, stability of the 
resultant protein and experimental reproducibility. Though commercially available 
systems are designed to be simple to use and easy to modify, the production 
process must be empirically evaluated and optimized accordingly, depending on the 
nature and qualities of the specific peptide produced (Schumann and Ferreira, 
2004). 
Smaller peptides may prove particularly problematic, specifically with regards to 
retaining their activity as shorter peptides are often rapidly degraded by proteases in 
E. coli (Douglas Fairlie et al., 2002). Production systems utilizing tag-proteins (such 
as the GST-tag) are especially effective for producing small biologically active 
antimicrobial peptides by rendering them inactive when fused to the much larger tag 
protein.  
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Vv-AMP1, the first defensin isolated from grapevine, is a small, cysteine-rich 
peptide. This 77-amino acid shows strong similarity to plant defensins and is 
expressed in the berry only at the onset of berry ripening. The tertiary structure of 
Vv-AMP1 reveals a typical defensin structure, consisting of an α-helix with a triple-
stranded anti-parallel β-sheet. These are stabilized by disulfide linkages between 
eight cysteine residues. The peptide is non-morphogenic and treated fungi show no 
signs of hyperbranching but it has a compromising effect on fungal membranes. Vv-
AMP1 is stable even at high temperatures, retaining up to 62% activity after 
treatment for 30 minutes at 100ºC. The peptide inhibited the growth of different plant 
pathogenic fungi at very low concentrations. (De Beer and Vivier, 2008). 
Production of the Vv-AMP1 peptide had previously been attempted using the 
His-tag fusion system. This method proved unsuccessful, as it seemed the His-tag 
was insufficient to inhibit the activity of the peptide and upon induction, the produced 
peptide negatively impacted the E. coli cells producing it, leading to extremely low 
yields (personal communication, Dr. Abrè de Beer, IWBT, Stellenbosch University). 
Subsequent production of Vv-AMP1 was achieved successfully, resulting in 
biologically active peptide, but at very low yields (De Beer and Vivier, 2008). 
Improving production of Vv-AMP1 with the GST-tag fusion system to increase both 
yield and purity of the peptide required meticulous refinement of each step in the 
production process. 
The system proved sensitive to slight changes in growth and induction 
conditions, and optimization of the first step was necessary to ensure adequate 
production of the fusion protein. Also, while induction at high cell densities and for 
extended periods might increase the yields of the fusion protein, it risks the formation 
of inclusion bodies (Saluta and Bell, 1998). With this in mind, growth and induction 
parameters were varied by lowering the induction temperature, shortening the 
induction time and increasing the aeration of the culture during induction. Induction 
proved optimal for 5 hours at room temperature, leading to a marked improvement in 
production of the fusion peptide. Both shorter and longer induction times led to a 
decrease in peptide production, as did induction at higher temperatures (e.g. 37°C). 
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The binding of GST to the glutathione Sepharose 4B is a highly specific 
interaction. This reduces the occurrence of non-specific interactions by other 
proteins and peptides with the sepharose. When non-specific binding was observed, 
increasing the salt concentration of the binding buffer to 300 mM served to reduce it. 
Increasing the volume of wash buffer used also aided in removing unwanted proteins 
and substances interacting with the column. 
The inefficient elution of the GST–VvAMP1 fusion peptide was addressed by 
increasing the concentration of reduced glutathione in the elution buffer from 10 mM 
to 50 mM. Enzymatic removal of the GST tag through thrombin protease digestion 
was improved by using a more efficient thrombin, acquired from Amersham 
Biosciences. Both manufacturers’ thrombin proteases should be suitable to cleave 
the Vv-AMP1 from the GST tag, but the Amersham thrombin proved much more 
efficient when compared to that of Novagen. Still, cleavage was sub-optimal, with 
large amounts of uncleaved GST-VvAMP1 still present in samples after overnight 
digestion. This inefficient cleavage may be explained by sub-optimal cleavage 
conditions and requires further investigation to ensure optimal cleavage and 
complete removal of Vv-AMP1 from the GST tag. 
The production and purification of the GST-VvAMP1 fusion peptide was 
markedly improved through the optimizations investigated in this study, leading to a 
noticeable increase in yield of purified peptide when compared to the standard 
method of production. De Beer and Vivier (2008) reported up to 5 mg/L of purified 
recombinant peptide, while this study yielded nearly double that. Despite this 
improvement in initial yield, the cleavage of the Vv-AMP1 peptide remained 
problematic. When the purified peptide was tested against fungal pathogens known 
to have their growth inhibited by Vv-AMP1, the peptide showed no inhibitory activity.  
The purified Vv-AMP1 also exhibited uncharacteristic instability, showing signs 
of degradation within a week of purification, even when stored under optimal 
conditions. This is in contrast to the results obtained regarding the intrinsic stability of 
the purified peptide, as reported by De Beer and Vivier (2008). 
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Both the inactivity and instability of the resultant peptide could be a result of 
incorrect folding of the peptide after cleavage. This would render the peptide unable 
to inhibit antimicrobial growth as normal and also affect the stability of the peptide, if 
the incorrect folding affects or changes the peptide structure. Incorrect folding of the 
peptide may be ascribed to the absence of necessary co-factors or molecular 
chaperones that are not present in the prokaryotic intracellular environment. Though 
the E. coli strains used in recombinant expression systems are engineered to reduce 
the occurrence of codon bias, the organism’s ability to produce the desired peptide 
might still be inhibited, especially if the gene expressed is rich in codons rarely used 
by E. coli, codons such as AGA and AGG, coding for arginine (Makrides, 1996). 
For the optimizations described in this study regarding improved production to 
be meaningful, it is imperative that issues around cleavage and removal of the tag, 
peptide inactivity and peptide instability be further investigated and suitably 
addressed. Cleavage efficiency must be explored, specifically looking at cleavage 
conditions other than optimal temperature and length of cleavage. Other conditions 
such as amount of thrombin protease used per mg of fusion protein or the 
composition of the cleavage buffer may have an effect on the efficiency of the 
cleavage (Jenny et al., 2003). 
After cleavage of the Vv-AMP1 peptide is optimal and yields of purified, cleaved 
peptide are increased, the activity and stability of the resultant peptide can be re-
evaluated. Alternatively, if these issues remain unsolved, it might be prudent to 
investigate the use of a different expression system to circumvent the difficulties 
currently presented by using the GST-fusion system.  
Recombinant expression systems utilizing eukaryotic host organisms (such as 
the Pichia pastoris expression system) may aid in overcoming problems of codon 
bias and the lack of molecular chaperones to ensure the correct amino acid 
sequence and subsequent correct folding of the eukaryotic gene being expressed. 
Other expression systems make use of non-enzymatic methods to cleave the tag 
from the target protein, some through the addition of dithiothreitol (DTT) to induce 
self-cleavage of intein splicing elements present in the fusion protein; others induce 
cleavage through a change in temperature or pH. These systems eliminate lengthy 
enzymatic cleavage steps from the protocol, which reduces the risks of enzymatic 
degradation and destabilizing of the protein. 
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4.1 Abstract 
The importance of cysteine-rich, small antimicrobial peptides in the pre-existing 
defense system of plants is becoming increasingly apparent. Plant defensins are 
ubiquitous defense peptides in the plant kingdom and are an integral part of the 
innate immune system. Vitis vinifera antimicrobial peptide 1 (Vv-AMP1) is the first 
plant defensins isolated from grapevine. This 77 amino acid peptide is only 
expressed in berries at the onset and duration of berry ripening. The peptide showed 
strong activity against a range of fungal pathogens, including Botrytis cinerea, 
Fusarium oxysporum and Verticillium dahliae. Here we further investigated the 
functional characteristics of the peptide, both in vitro and in planta. In in vitro 
antifungal assays, Vv-AMP1 showed strong activity against the following grapevine 
pathogens: Phomopsis viticola, Diplodia seriata, Phaemoniella chlamydospora, and 
Cylindrocarpon liriodendri. Microscopic analysis of peptide-treated fungal cultures 
confirmed a strong membrane disruption activity by the peptide. The peptide was 
further evaluated for its in planta role by overexpression in its native host. Putative 
transgenic lines of V. vinifera (cv. Sultana), transformed with an expression cassette 
containing Vv-AMP1 and a constitutive promoter, were obtained and the presence 
and expression of the transgene could be confirmed in nine independently 
transformed lines. Some of the lines exhibited abnormal growth in the in vitro as well 
as the hardened off state. Leaf shape and growth point development was affected in 
some lines. In a first analysis of the in planta effect of Vv-AMP1 in its native host, the 
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transgenic lines were evaluated by challenging the population with B. cinerea using a 
detached leaf infection assay. Symptom development proceeded over a six day 
period and statistical evaluation of the data showed that the transgenic lines 
behaved as a population and could not be distinguished from each other in terms of 
lesion sizes, but all lines could be separated from the untransformed control.  
4.2 Introduction 
The management and prevention of disease in crops has become a global industry 
that is continually searching for new and improved methods of controlling the 
incidence and spread of disease. Grapevine has been one of the world’s most 
cultivated and economically important food crops for centuries. The importance of 
finding ways to improve the resistance of the crop to disease is significant (Troggio 
et al., 2008). The wine and table grape industry is faced with a considerable number 
of pathogens that specifically attack grapevine. For many of these diseases an 
effective method of prevention and/or control has yet to be developed. 
It is known that plants have complex defense systems to recognize pathogens 
and to mount protective measure against invading pathogens. Understanding these 
pathways and the roles of the proteins and metabolites involved is paramount to 
develop efficient strategies for pathogen control. Functional analysis of known 
classes of defense proteins is an important part of the detailed analysis of how plants 
respond to infection. One of the defense mechanisms used by plants involves 
antimicrobial peptides (AMPs) that form part of the innate immunity of plants. It is 
known that these peptides are over-represented in plant genomes and that different 
classes share structurally similar motifs. Typical defensin structure consists of an α-
helix and a triple-stranded, anti-parallel β-sheet. This structure is stabilized by 
disulfide bonds between cysteine residues, of which there characteristically are 
eight. These conserved structures are central to their proposed modes of action.  
The first grapevine defensin was recently isolated and characterized to be a 
non-morphogenic plant defensin that inhibits fungal growth through membrane 
permeabilization (De Beer and Vivier, 2008). Moreover, the peptide has been shown 
to be expressed only from the onset of berry ripening and expression was non-
inducible through wounding, infection of hormone treatments (De Beer and Vivier, 
2008). The peptide had strong antifungal activity against Botrytis cinerea, Fusarium 
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solani, F. oxysporum and Verticillium dahliae under in vitro conditions. 
Overexpression of this defensin in transgenic tobacco, however, led to inconclusive 
results regarding its ability to decrease disease susceptibility against B. cinerea in 
this host, partly due to overlapping peptide activities present in the tobacco host (De 
Beer, 2008). Infection studies using grapevine pathogens with model plant systems 
such as tobacco may not yield meaningful results, as these pathogens are unlikely to 
infect non-host plants.  
Following the previous work, purified Vv-AMP1 was evaluated against a panel 
of grapevine pathogens that could be cultured and sporulated in plate assays to 
determine the in vitro antifungal activity. These pathogens include: Phomopsis 
viticola, which causes cane and leaf spot and infects leaves, shoots and stems; 
Phaemoniella chlamydospora, which is involved in Petri disease (also called Esca, or 
“black goo” disease) and infects the woody tissue of trunks; Cylindrocarpon 
liriodendri, which causes black foot and infects the roots, crown and rootstock and 
Diplodia seriata which causes “black dead arm” disease, infecting the internal tissues 
of stems and trunk and may also cause bunch rot.  
 The peptide proved highly effective at inhibiting growth of all pathogens tested, 
some at extremely low concentrations (4.6 µg/ml). Moreover, to facilitate in vivo 
analysis of Vv-AMP1 against grapevine pathogens, a putative transgenic population 
of V. vinifera cv. Sultana overexpressing the peptide was obtained and genetically 
and phenotypically characterized. The transgenic population was challenged with B. 
cinerea in a detached leaf infection assay to evaluate a potential resistance 
phenotype.  
 
4.3 Materials and Methods 
 
4.3.1  Plant material and microbial strains 
A putatively transformed population of V. vinifera (cv. Sultana) was obtained from the 
grapevine transformation and regeneration platform of the IWBT (the transformations 
were kindly performed by Dr. Krishnan Vasanth). Agrobacterium tumefaciens strain 
EHA 105, transformed with a binary expression vector containing Vv-AMP1 
(constructed by Dr. A. De Beer and reported in De Beer, 2008), was used for the 
transformation of grapevine as described by Franks et al. (1998). The plant 
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expression vector drives the constitutive expression of Vv-AMP1 through the 
CaMV35S (cauliflower mosaic virus Cabb B-JI isolate 35S) promoter and the OCS 
(octopine synthase) terminator while the kanamycin resistance gene is under the 
control of the nopaline synthase gene promoter and terminator (Pnos and Tnos) and 
provided the antibiotic resistance marker to select transformed cells and putative 
transformed plantlets from untransformed material. Putative transgenic plants were 
maintained on Murashige and Skoog basal salt mixture (Murashige and Skoog, 
1962) in a growth chamber. A number of plantlets for each individual transgenic line 
were clonally propagated from the primary transformants, hardened off and 
maintained in a greenhouse at 25°C and moderate humidity.  
All fungal isolates were obtained from Department of Plant Pathology (DPP) 
Stellenbosch University with the exception of B. cinerea which was obtained from the 
IWBT culture collection. Table 4.1 lists all pathogen strains used in this study as well 
as specific growth and sporulation conditions for each strain. 
 
Table 4.1 Growth and sporulation media and incubation period to obtain sporulating cultures 
of grapevine pathogens used in this study. (Culture and sporulation conditions are described 
as recommended by Dr. Lizel Mostert, Department of Plant Pathology, Stellenbosch 
University) 
Fungal species Isolate number Sporulation media Incubation period to 
obtain sporulating 
cultures 
Botrytis cinerea 
 
N/A Potato dextrose agar 
(PDA) 
1 week 
Diplodia seriata 
 
STE-U 4440 Oatmeal Agar (OA) 
 
2 – 4 weeks 
Phaeomoniella 
chlamydospora 
 
STE-U 6364 PDA 2 – 4 weeks 
Cylindrocarpon 
liriodendri 
STE-U 6171 PDA  2 weeks 
Phomopsis viticola STE-U 5916 PDA/OA  2 – 4 weeks 
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4.3.2 PCR screen and Southern Blot analysis of transgenic lines transformed 
with VvAMP1  
Transgenic grapevine lines transformed with the VvAMP1 gene were PCR screened 
and analyzed by Southern Blot to confirm the integration of the transgene and 
determine the copy number of each line. 
For genomic DNA extraction, harvested grapevine leaf tissue was frozen in 
liquid N2 and ground to a fine powder. Extractions were performed in accordance 
with an established protocol (Steenkamp et al., 1994).  
To confirm positive integration of the Vv-AMP1 cassette, PCR was performed 
using the GoTaq system (Promega, Madison, WI, USA). Genomic DNA extracted 
from transgenic grapevine lines was used as template and together with the primer 
set Hs-AFP1-5’ (5’-GCCGCTCGAGTATTTTTACAACAATTACCAAC-3’) and Vitisdef 
-3’ (Vitisdef-3 (5-CCGGATCCTTAACAATGCTTAGTGC-3). 
To determine the number of integrated copies of the transgene in each 
transgenic line, 50 µl of genomic DNA was digested with XbaI and BglII in Buffer 2X 
Tango™ (Fermentas). The digested DNA was separated on a 1% (w/v) agarose gel 
and thereafter transferred overnight to a positively charged nylon membrane 
(Amersham Biosciences, NJ, USA) as described by Sambrook et al. (1989). After 
transfer, the membrane was UV-cross linked to prevent loss of DNA. The 
membranes were suitably probed with a DIG-labeled VvAMP1 probe. Pre-
hybridization and hybridization was performed at 37oC using DIG Easy-Hyb granules 
(Roche Diagnostics GmbH, Mannheim, Germany). Detection was performed with 
CSPD according to the manufacturer’s protocol (Roche Diagnostics GmbH, 
Mannheim, Germany).  
 
4.3.3 RNA isolation and Northern Blot analysis of transgenic lines transformed 
with VvAMP1 
Isolation of RNA was performed according to the protocol of Chang et al. (1993). 
Total extracted RNA was separated on a 1.2% (w/v) formaldehyde gel. The gel was 
rinsed in DEPC-treated dH2O and transferred to positively charged nylon 
membranes (Sambrook and Fitsch, 1989). The membranes were UV-cross linked 
where after pre-hybridization and hybridization took place at 50°C. The membranes 
were suitably probed with a DIG-labeled Vv-AMP1 probe. Detection was performed 
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with CSPD according to the manufacturer’s protocol (Roche Diagnostics GmbH, 
Mannheim, Germany) 
 
4.3.4 Antimicrobial activity of purified Vv-AMP1 peptide against pathogens 
The quantitative antifungal activity of the antifungal peptides was measured using a 
microspectrophotometric antifungal assay (Broekaert et al., 1990). Purified Vv-AMP1 
peptide was obtained from the IWBT; details of the purified peptide were described 
in De Beer and Vivier (2008). The assay was performed in a 96 well microtiter plate 
(Nunc, Roskilde, Denmark). Each individual reaction contained 100 µl half strength 
PDB with 2000 fungal spores and a range of peptide concentrations. The control 
wells contained no peptide. Reactions were done in triplicate. The plates were 
incubated in the dark at 25°C for 2 days. Microspectrophotometric readings were 
taken every 24 hours at 595 nm. 
Measurements (A595) were taken at 0 h, 24 h and 48 h using a PowerwaveX 
microplate reader (Bio-Tek instruments inc.). Values were corrected by subtracting 
the 0 h value from the 24 h and 48 h measurements. Activity is expressed in terms of 
the percentage growth inhibition and can be calculated with the formula: 


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Microscope images were simultaneously obtained from the antifungal assays 
with an Olympus IX70 inverted microscope. Images were captured with the 
Analysis® software (Olympus Soft Imaging Solutions GmbH). The ability of Vv-AMP1 
to permeate the fungal membrane was evaluated using a propidium iodide (PI) 
uptake assay (Gangwar et al., 2006). The permeabilization assay consisted of 200 µl 
half-strength potato dextrose broth, 2 x 104 ml-1 fungal spores. Samples were 
incubated at 25ºC for 48 h. After incubation, the samples were treated with Vv-AMP1 
for 15 minutes, then washed with phosphate-buffered saline (PBS) and stained for 
10 min in PI staining solution (25 µg/ml PI in PBS). Samples were viewed with an 
Olympus IX 81 inverted fluorescent microscope. Images were captured using the 
CelliR® digital camera and software system (Olympus Soft Imaging Solutions 
GmbH). PI reacts with nucleic acids but is unable to cross the fungal membrane. The 
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presence of fluorescence is therefore an indication of compromised fungal 
membranes. 
 
4.3.5 Detached leaf infection assays 
VvAMP1 transgenic Sultana lines were challenged with B. cinerea through detached 
leaf infection assays. Leaves were harvested from plants growing under greenhouse 
conditions. Four individual transgenic lines were chosen at random and three plants 
from each individual line were tested. Untransformed Sultana plants were used as 
control plants. Three leaves were harvested from each plant. Leaves chosen were 
fully developed and expanded. Leaves were placed in sterilized plastic containers on 
sterilized Whatman paper, moistened slightly with sterilized dH2O. Containers were 
closed tightly and leaves were pre-conditioned for 24 h by placing containers in an 
infection room at a constant temperature of 25°C.  
Dry B. cinerea spores were hydrated in sterilized dH2O, 24 h prior to infection. 
On the day of infection, spores were counted and diluted in 50% grape juice. 
Pre-conditioned leaves were inoculated with prepared B. cinerea spores by 
spotting 10 µl of spore suspension onto the surface of the leaf. Each spot contained 
2000 spores. Approximately 4-6 spots were made per leaf, depending on leaf size. 
Infections were followed for six days, both visually and by recording lesion sizes at 
24 hour intervals. Differences in lesion sizes were plotted daily and the course of the 
infection was photographed.  
 
4.3.6 Statistical analysis 
A custom program was written in perl to parse the data (Jacobson, 2010), calculate 
the means and standard deviations and perform an all-against-all set of t-tests to 
determine if there were significant differences (p value < 0.05) between plant lines at 
each time point for each of the detached leaf infection assays. A graph was created 
to represent the statistical relationships amongst the plant lines with an edge created 
whenever two plant line populations were statistically indistinguishable from one 
another. The resulting graph was visualized in Cytoscape (Shannon et al., 2003; 
Cline et al., 2007). 
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4.4 Results 
4.4.1 In vitro analysis of Vv-AMP1 against grapevine pathogens 
Purified Vv-AMP1 peptide was tested in vitro against a selection of fungal pathogens 
that cause serious diseases of grapevine. The pathogens selected were those that 
can be cultured on plates to sporulate and were evaluated for their sensitivity 
towards Vv-AMP1 using a dose-response growth inhibition assay. Vv-AMP1 showed 
a marked inhibition of antifungal growth when tested against Diplodia seriata (Figure 
4.1), Cylindrocarpon liriodendri (Figure 4.2), Phomopsis viticola (Figure 4.3) and 
Phaemoniella chlamydospora (Figure 4.4). Figures 4.3(B) and 4.4 present the results 
of assays accurately determining the IC50 values of the Vv-AMP1 peptide for P. 
viticola and P chlamydospora, respectively. In all assays, the control samples show 
exponential growth over 48 hours while the assays containing 4.8 µg/ml and 9.6 
µg/ml of peptide respectively are severely inhibited after only 24 hours of growth, as 
well as after 48 hours.  
The assays were performed in triplicate and standard deviation was calculated 
and is represented by error bars.  
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Figure 4.1 Antifungal activity of Vv-AMP1 against B. obtusa over a period of 48 hours. 
Samples treated with 4.8 mg/ml and 9.6 mg/ml respectively both show inhibition of growth 
when compared to control after 48 hours. 
Figure 4.2 Antifungal activity of Vv-AMP1 against C. liriodendri over a period of 48 hours. 
Samples treated with 4.8 mg/ml and 9.6 mg/ml respectively both show inhibition of growth 
when compared to the control sample after 24 hours. After 48 hours, the sample treated with 
4.8 mg/ml of peptide showed moderately inhibited growth and the sample treated with 9.6 
mg/ml peptide showed severe inhibition of growth. 
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Figure 4.3 (A) Antifungal activity of Vv-AMP1 against P. viticola over a period of 48 hours. 
Samples treated with 4.8 mg/ml and 9.6 mg/ml respectively both show inhibition of growth 
when compared to the control sample after 24 hours. After 48 hours, the sample treated with 
4.8 mg/ml of peptide showed slightly inhibited growth and the sample treated with 9.6 mg/ml 
peptide showed severe inhibition of growth. (B) Antifungal activity of Vv-AMP1 against 
Phomopsis viticola expressed as a percentage of growth of the control sample. The 
concentration of Vv-AMP1 peptide required to inhibit fungal growth by 50% is 4.0 µg/ml. 
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Figure 4.4 Antifungal activity of Vv-AMP1 against Phaemoniella chlamydospora expressed 
as a percentage of growth of the control sample. The concentration of Vv-AMP1 peptide 
required to inhibit fungal growth by 50% is 5.5 µg/ml. 
Figure 4.5 (A – F) Light microscope images of B. cinerea (A-C) and P. viticola (D-F) treated 
with different amounts of Vv-AMP1 peptide. A and D are the control samples of each 
pathogen respectively, B is treated with 20 µg/ml, C is treated with 30 µg/ml, E is treated 
with 4.8 µg/ml and F with 9.6 µg/ml. 
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Figure 4.6 (A – C) Microscope images of P. viticola cultures grown untreated for 24 hours, 
then treated with 13 µg/ml Vv-AMP1 and propidium iodide (PI). A is the light microscope 
image, B is the fluorescent microscope image and C is an overlay of the two images. The 
fluorescence is an indication of a compromised membrane. 
Microscopic analysis of the in vitro assays revealed severe effects on fungal 
growth in samples treated with the purified peptide (Figures 4.5 and 4.6). All treated 
cultures showed severe reduction of hyphal elongation and biomass development. 
When present in high concentrations, spore germination was also inhibited by the 
presence of the peptide (Figure 4.5 C and F). This was observed in two of the 
pathogens, B. cinerea and P. viticola. No microscopic analysis of the other 
pathogens was performed. P. viticola proved a great deal more sensitive to the 
peptide than B. cinerea, being inhibited at much lower concentrations of Vv-AMP1. 
Figure 4.6 shows a propidium iodide (PI) uptake assay where P. viticola was first 
grown for 24 hours without the presence of the peptide. Shortly before the images 
were taken, the samples were treated with Vv-AMP1 and subsequently stained with 
PI. The visible fluorescence seen in the treated samples indicated that the fungal 
membranes were severely compromised within 15 minutes after treatment with the 
Vv-AMP1 peptide.  
Microscopic analysis also confirmed the previous observation by De Beer and 
Vivier (2008) that Vv-AMP1 does not cause hyperbranching in treated cultures.  
 
4.4.2 Analysis of a transgenic grapevine population overexpressing Vv-AMP1 
Twenty five putative transgenic lines of V. vinifera (cv. Sultana) transformed with the 
Vv-AMP1 expression cassette was kindly obtained from Dr. Krishnan Vasanth from 
the IWBT transformation and regeneration facility and subjected to genetic and 
phenotypical analysis. The genetic analysis included PCR, Southern and northern 
blot analysis (Figure 4.7 and Table 4.2). PCR screening confirmed the presence of 
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the transgene in all lines of the putative transgenic population. Untransformed V. 
vinifera material was used as control. No amplified product is detected in the control 
lines as the primers are designed to amplify a copy of the transgene which includes 
a part of the expression cassette, preventing amplification of the native gene (Figure 
4.7 A). Southern blot analysis revealed nine individually transformed transgenic 
lines, as seen by the individual banding patterns. Untransformed lines indicated two 
native copies of the Vv-AMP1 gene and transgenic lines showed multiple copies, 
with each band representing an integration of the Vv-AMP1 transgene (Figure 4.7 B). 
All nine individual transgenic lines tested northern blot positive, confirming 
expression of the Vv-AMP1 gene. The native gene is not expected to be expressed 
in untransformed lines since the native Vv-AMP1 gene is only expressed in berry 
tissue at the onset of berry ripening, and not in leaves. Any expression detected in 
Northern blot analysis thus indicates the expression of the transgene (Figure 4.7 C). 
Figure 4.7 (A - C) shows examples of PCR screens, Southern and northern blot data 
whereas Table 4.2 summarizes the results of the molecular characterization of the 
transgenic V. vinifera lines overexpressing Vv-AMP1. 
 
Table 4.2 Summary of molecular characterization of nine transgenic V. vinifera (cv. Sultana) 
lines overexpressing the Vv-AMP1 plant defensin. Characterization included PCR screening, 
Southern and Northern blot analysis. Number of integrations refers to the number of copies 
of the VvAMP1 transgene integrated into the genome. A “+” denotes a positive result and a 
“-“ a negative result. WT indicates the untransformed V. vinifera cv. Sultana lines used as 
control. 
Plant line WT 6 7 8 9 10 14 17 18 19 
PCR - + + + + + + + + + 
Southern 
Blot 
+ + + + + + + + + + 
Northern 
Blot 
- + + + + + + + + + 
Number of 
transgene 
Integrations 
0 2 6 2 3 2 3 2 2 5 
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Figure 4.7 (A - C) Representative examples of PCR screen (A), Southern (B) and Northern 
(C) blots indicating integration and expression of Vv-AMP1 in the transgenic V. vinifera lines. 
Lanes marked M denote molecular markers (Fermentas Lambda PstI marker). WT denotes 
the untransformed control lines and numbered lanes indicate putative transgenic lines. 
Figure 4.8 (A-C) Normal growth phenotype (A) compared to abnormal growth phenotypes 
observed in transgenic Vv-AMP1 lines 19 (B) and 17 (C). Leaves showed unusual growth 
and formation when compared to typical V. vinifera cv. Sultana development. 
  
A  B  C 
 
 
M     WT    1      2      4       6       7       8      9     10    14    17     18    19     20   21    24    25   26    27 
M    WT     2      3      4      5       6      7      8      9     10    14    17    18    19     20    21     22    24 
M       WT         6          7          8          9         10      14          17        18     M       M  19 
C 
B 
A 
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Lines that were confirmed to be independent transgenic lines with transgene 
expression were multiplied and hardened off. Phenotypically, most of the lines 
appeared similar to the control in terms of growth speed, plant size and general 
appearance of the vegetative organs, but some lines (lines 19 and 17) showed 
abnormal leaf morphology as well as altered internode/node arrangements (Figure 
4.8). These growth phenotypes showed no correlation to number of integration 
events. A subset of lines were randomly selected for infection with B. cinerea to 
investigate the in planta defense response of the overexpressed lines. Of the 
grapevine pathogens tested in vitro, B. cinerea was not the most sensitive organism 
to the Vv-AMP1 peptide, but it provides a convenient pathosystem in grapevine as it 
infects leaves, whereas the other selected pathogens typically infect woody stems 
and established leaf infection systems are not available. 
For this first screen, a detached leaf assay was used where three fully 
expanded leaves of three clonal copies of lines 6, 14, 18 and 19 were infected with 
four to six spots per leaf. B. cinerea rapidly infected both transgenic and 
untransformed leaves and primary lesions were visible on all leaves after 2 days of 
incubation at 25°C and 100% humidity. Spreading lesions developed after that and 
lesion sizes (diameter in mm) were measured daily for six days. After day 5, 
accurate measurements became difficult as lesions tended to flow into one another. 
The overall infection rate was 95%.  
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Figure 4.9 (A-E) Lesion formation on detached grapevine leaves, six days after infection 
with B. cinerea. Panel A shows lesion formation on an untransformed control leaf, two days 
after infection. Panel B shows untransformed V. vinifera cv. Sultana line used as the control. 
Six days after infection, the control leaf is mostly colonized by the pathogen. Panels C to F 
represent transgenic Vv-AMP1 lines 6, 14, 18 and 19, respectively. Lines 6 and 19 visually 
appear to show a higher degree of resistance to infection with slightly smaller lesions when 
compared to the control line and transgenic lines 14 and 19. 
Figure 4.10 Measurements of average lesion size of detached leaves infected of both 
transgenic Vv-AMP1 grapevine lines and untransformed control lines with B. cinerea, six 
days after inoculation and growth at 25°C and 100% humidity. The graph indicates the 
average lesion size of the over a period of six days. Error bars denote the standard deviation 
of the data analyzed. After six days, transgenic lines 6 and 19 suggest a marginally higher 
degree of resistance when compared to the control line. 
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Typical lesion appearance at the end of the experiment is shown in Figure 4.9 
and the average lesion sizes over the infection period are shown in Figure 4.10. 
From this detached leaf assay against B. cinerea, it is observed that the 
overexpression leads to a mild resistance phenotype when compared to the control. 
Statistical analysis of the lesion measurements, where a t-test was used to evaluate 
and compare all lesions against one another, indicated that the transgenic population 
could be separated from the untransformed control based on lesion sizes (Figure 
4.11). 
 
Figure 4.11 Visual representation of statistical analysis (generated through Cytoscape) 
signifying the statistical relationships between untransformed control lines (“Wild type”) and 
transgenic Vv-AMP1 (VvAMP1_6, VvAMP1_14, VvAMP1_18 and VvAMP1_19) plant lines. 
A blue line denotes the statistical relationship between plant lines. An edge is created 
whenever two plant lines are statistically indistinguishable from one another. The graph 
indicates while all four transgenic Vv-AMP1 lines are indistinguishable from one another, the 
control line is distinguishable from the transgenic lines. This significant difference suggests a 
higher degree of resistance of the transgenic lines when compared to the untransformed 
controls.  
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4.5 Discussion 
The focus on increasing the disease resistance of crops to pathogen attack through 
recombinant DNA technology has been increasing in recent years. A number of such 
recombinant resistance studies on a variety of crop plants transformed with genes 
encoding for antifungal peptides have been completed (Aerts et al., 2007; Swathi 
Anuradha et al., 2008; Dai and Beachy, 2009; Zainal et al., 2009). These studies 
indicate that the introduction and overexpression of genes encoding for antifungal 
peptides have an effect in enhancing the plant’s natural defense against pathogen 
infection and disease. The active production of these antifungal peptides by the plant 
seems to provide the plant with the ability to inhibit fungal growth and slow down 
infection. 
The grapevine defensin Vv-AMP1 was highly effective against grapevine 
pathogens when used in in vitro antifungal assays. Not only does the peptide inhibit 
the growth (and, at very high concentrations, even germination) of the pathogens, it 
does this at remarkably low concentrations (as low as 4.0 µg/ml). This high level of 
activity, even at extremely low doses, makes it a peptide of interest for in planta 
disease resistance studies, the hypothesis being that if the plant expresses even low 
levels of peptide in the tissue, the presence of such a highly active peptide could 
significantly decrease the plant’s susceptibility to fungal infection. The microscopic 
analysis also confirmed the peptide to be non-morphogenic with a very strong 
membrane disruption activity (see Figure 4.5 and 4.6). 
Propidium iodide (PI) uptake assays showed clear fluorescence in the presence 
of Vv-AMP1. PI is incapable of crossing the intact microbial membranes of living 
cells and only fluoresces in the presence of nucleic acids. The fluorescence 
observed is therefore an indication of a compromised membrane. This supports the 
theory that the mode of action of the Vv-AMP1 peptide is associated with membrane 
permeabilization. Recent evidence has proposed the membrane disruption activity of 
the defensins to be a secondary response (Amien et al., 2010; van der Weerden et 
al., 2010). Moreover, these studies propose that an intact cell wall may be required 
for this specific mode of action (López-García et al., 2010). These studies suggest 
that the cell wall itself might play a role in the mode of action of defensins, possibly 
through interactions with proteinaceous receptors located in the cell wall (Amien et 
al., 2010). 
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 However, in our PI assays, membrane disruption appeared very quickly after 
treatment of hyphal culture with the Vv-AMP1 peptide. This indicates a strong 
membrane permeabilization interaction. It would be of interest to perform 
experiments to evaluate whether this response is dependent on other factors and 
whether it is indeed a secondary response rather than the primary mode of action. 
The possibility to evaluate the effectiveness of the Vv-AMP1 peptide against 
grapevine pathogens in in vitro assays are limited to pathogens that can be cultured 
on plates to form sporulating cultures. Many grapevine pathogens which cause 
economically damaging crop losses are not culturable and can therefore only be 
evaluated in an in planta environment. Previous overexpression analysis of this 
peptide in tobacco as a model plant (De Beer, 2008) is not useful in this regard, 
since many of these pathogens do not infect tobacco. To this end, a transgenic 
population of grapevine overexpressing the Vv-AMP1 peptide was obtained and 
genetically characterized. Nine independently transformed lines with confirmed 
transgene expression could be identified in this study. These lines are important 
resources to further characterize the in vivo role of the Vv-AMP1 defensin against 
grapevine pathogens. Individual plants from transgenic lines 17 and 19 showed 
abnormal growth phenotypes, with atypical leaf formation when compared to 
untransformed Sultana plants. Abnormalities were absent in most of the transgenic 
population, and atypical leaves were not used for infections. The uncharacteristic 
growth patterns could possibly be attributed to the effect of transgene integration 
patterns into the genome. 
Western blot analysis on these lines proved inconclusive (results not shown). 
The protein extraction methods tested were inefficient to isolate the smaller peptide 
fractions from leaf tissue. Furthermore, the compounds within the extraction buffers 
interfered with the Western blot analysis itself (data not shown). These extractions 
and analysis needs to be optimized and repeated to accurately determine the 
presence of the Vv-AMP1 peptide in leaves, stems or roots. Since the peptide 
presence could not be confirmed in the in planta environment with Western blot 
analysis, the presence were indirectly tested by evaluating the peptide activity in 
infection studies. The antifungal activity of the overexpressed peptide was evaluated 
through detached leaf infection assays against Botrytis. B. cinerea was chosen as a 
first screening organism, given its known ability to form lesions on infected leaves. 
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Comparison of transgenic lines with control lines after infection with B. cinerea, 
both in terms of lesion type and average lesion size that develop over a six day 
period, suggest that the transgenic lines have a marginally higher degree of 
resistance than the control. Statistical analysis of lesion measurements 
(incorporating means, standard deviations and t-tests) indicated that while all four 
transgenic lines tested were statistically indistinguishable from one another (and thus 
behaved as a population), they were all distinguishable from the control lines. 
The low level of improved disease resistance could possibly be attributed to 
various factors. B. cinerea is one of the more resistant pathogens tested against Vv-
AMP1, with IC50 values of 13 µg/ml. If Vv-AMP1 is present in the leaves of 
transgenic grapevine at relatively low levels, it will affect the resistance phenotype.  
Moreover, the detached leaf assay also activates a wound response prior to 
infection and this background defense response might mask the defense phenotype 
linked to the overexpression of Vv-AMP1. The infection assay should be followed by 
a whole plant infection assay to follow the defense phenotype against B. cinerea and 
other grapevine pathogens such as powdery and downy mildew without the 
interference of the wound response. The infection method should also be further 
optimized with regards to leaf age, position and developmental stage since these 
factors could also influence the susceptibility of the plant to the pathogen. Also, B. 
cinerea is known to secrete a number of substances during colonization and 
infection of a plant. These substances (such as cutinases, pectinases and 
proteases) may alter the apoplastic environment and interfere with the ability of the 
antimicrobial peptide to inhibit the fungal growth. Proteases secreted by the 
pathogen may serve to degrade defense proteins and peptides present in the 
apoplast (Prins et al., 2000). 
In conclusion, in vitro studies provided evidence that the Vv-AMP1 defensin is 
strongly active against grapevine pathogens. This promising result, in combination 
with a confirmed transgenic population of grapevine overexpressing the peptide, 
provides significant scope to evaluate the in vivo functions of the peptide in defense 
against grapevine pathogens. Furthermore, the small but significant increase in 
disease resistance obtained in the detached leaf infection with B. cinerea confirmed 
the peptide to be produced and active in the lines. The next step would be to 
challenge these lines with more sensitive grapevine pathogens in whole plant 
infection assays, as well as assays on stems for stem specific pathogens.  
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Many studies have shown that the targeted overexpression of antifungal 
peptides could lead to a stable transgenic plant with improved resistance against 
plant pathogens (Dai and Beachy, 2009; Zainal et al., 2009). Transgenic studies in 
grapevines overexpressing antimicrobial peptides (eg. Magainan-2) have shown 
promising results towards improved resistance and symptom reduction when 
challenged with pathogens such as A. vitis, B. cinerea, Erysiphe necator and U. 
necator. (Vidal et al., 2006; Rosenfield et al., 2010), but to date no strong, definite 
resistance has been established. The results obtained in this study warrants further 
investigation into the potential disease resistance of transgenic Vv-AMP1 grapevine, 
specifically against a wider range of grapevine pathogens. 
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GENERAL DISCUSSION AND CONCLUSION 
5.1 General discussion and conclusion 
The principle challenge facing modern agriculture in recent years has unquestionably 
been achieving and maintaining sustainable agriculture through increasing and 
improving crop yields and quality while simultaneously lowering production costs. 
The world’s rapidly growing population and changes in climate and environmental 
conditions have only added to the urgency of finding solutions to address these 
challenges. One of the key problems experienced by modern agriculture is the 
efficient management of crop pests and diseases (Walker, 1983; Shah, 1997). Crop 
losses attributed to pest and disease annually is significant and preventing or 
reducing such losses would be of great fiscal value, specifically for economically 
important food crops, such as corn, soy, rice and grapevine. 
While disease management of crops has in the past depended heavily upon the 
use of regular chemical treatments, recent concerns have been raised regarding the 
long-term effects of pesticides and fungicides on both the environment and human 
health. The excessive use of chemicals has also led to resistant pathogen strains, 
which are no longer affected by fungicide treatment. These issues have required 
research to investigate safer, more sustainable alternatives to combat the 
occurrence and spread of disease (Lewis and Papavizas, 1991; Harms, 1992).  
In this search for safer, more effective solutions to the problem researchers 
have begun to turn to the plant’s natural ability to defend itself. Through exploring 
and understanding the natural defense mechanisms of plants (including antimicrobial 
peptides and plant defensins) strategies can be developed to harness these naturally 
developed systems. Through genetic engineering approaches even susceptible 
crops can be protected against disease (Montesinos, 2007; Swathi Anuradha et al., 
2008; Dai and Beachy, 2009). 
The discovery of the first grapevine defensin, Vv-AMP1, has created an 
opportunity to investigate the potential of this novel peptide as a tool to explore and 
improve the natural ability of grapevine to defend itself against pathogen attack.  
The Vv-AMP1 gene was isolated from Vitis vinifera and showed high sequence 
homology to plant defensins. Extensive work done by De Beer and Vivier (2008) to 
characterize the peptide found it to be highly developmentally regulated, being 
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expressed only in the berry and only at the onset of berry ripening. Expression could 
not be induced through wounding, infection with a pathogen or hormone treatment 
(De Beer and Vivier, 2008).  
Investigation into the signal peptide showed that Vv-AMP1 accumulated in the 
apoplastic region. Recombinantly produced Vv-AMP1 was further characterized and 
found to have a molecular mass of 5.495 kDa as determined by mass spectrometry. 
The peptide proved extremely heat stable and showed antifungal activity against 
most pathogenic fungi tested, specifically against Fusarium oxysporum, F. solani, 
Verticillium dahliae and Botrytis cinerea (De Beer and Vivier, 2008). Vv-AMP1 was 
overexpressed in tobacco, but infection assays failed to conclude that the presence 
of the peptide caused a decreased susceptibility of the host plant to pathogen 
infection when tested against B. cinerea (De Beer, 2008).  
The scope of this project was to further investigate the potential of Vv-AMP1 
and supplement existing information gained from the work of De Beer and Vivier 
(2008). This included evaluating and characterizing the antifungal activity of the 
peptide against a panel of grapevine-specific pathogens as well as studying the 
effect of peptide overexpression of the peptide within its native host, V. vinifera. The 
results of this study furthered our knowledge of the Vv-AMP1 grapevine defensin and 
yielded valuable resources for subsequent studies into grapevine disease resistance. 
This is the first report of a grapevine defensin functionally analyzed in grapevine and 
one of very few studies of defensins within this host.  
The objectives of this study (as outlined in Chapter 1) have been met and the 
major findings of the study can be summarized as follows: 
The promising results obtained from initial in vitro antifungal assays (De Beer 
and Vivier, 2008) prompted further investigation of the antifungal activity of the 
peptide, specifically against a panel of grapevine-specific pathogenic fungi. For in 
vitro testing, the peptide was required in pure, biologically active form.  
Subsequent efforts to recombinantly produce Vv-AMP1 in Escherichia coli 
using the pGEX-2T system proved problematic, prompting investigation and 
optimization of the production protocol. A number of steps in the production and 
purification protocol were targeted for improvement, including parameters 
surrounding the induction conditions as well as multiple steps throughout the 
purification procedure.  
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Despite successfully improving the production purification protocol and 
increasing yield nearly two-fold, the resultant peptide remained biologically inactive 
and unstable. This is uncharacteristic of the peptide as described by De Beer and 
Vivier (2008). Both the lack of activity and the observed peptide instability suggests 
that the produced peptide may not be structurally correct. This could be resultant of 
incorrect folding after cleaving the peptide from the GST-tag. This may be ascribed 
to an absence of essential co-factors or molecular chaperones that are not found in 
the intracellular environment of E. coli. Another feasible explanation is the 
occurrence of codon bias, inhibiting the organism’s ability to produce the desired 
peptide with the correct amino acid sequence. Incorrect folding may alter the 
structure of the peptide, in turn affecting activity and stability. 
Though attempts to recombinantly produce Vv-AMP1 failed to produce active 
peptide, a sample of biologically active Vv-AMP1 (obtained from Dr. A. De Beer, 
Institute for Wine Biotechnology, Stellenbosch University) was available for in vitro 
antifungal assays.  
Vv-AMP1 was tested against a panel of grapevine-specific pathogenic fungi, 
chosen based on their ability to be cultured and sporulate on plates containing 
appropriate growth media. Since a number of the most economically damaging 
grapevine pathogens (such as powdery and downy mildew) are not culturable, they 
can only be tested in an in planta environment and as a result were not suitable for 
the purposes of this study. 
 Results of the antifungal assays indicated that the Vv-AMP1 peptide was 
highly active against all the grapevine pathogens tested. Propidium iodide (PI) 
uptake assays were used to evaluate the mode of action of the Vv-AMP1 peptide. 
Membrane disruption appeared rapidly after treatment of the fungal culture with Vv-
AMP1 (within 15 minutes). This correlates with the suggested hypothesis that the Vv-
AMP1 peptide acts through membrane permeabilization. While recent studies 
(Amien et al., 2010; van der Weerden et al., 2010) suggest that the membrane 
disruption activity of defensins may be a delayed secondary response and that intact 
cell walls may be required for this specific mode of action, the rapid effect of Vv-
AMP1 on the fungal membrane indicates a strong and almost instantaneous 
membrane permeabilization effect.  
For in planta evaluation of Vv-AMP1, a population of transgenic V. vinifera (cv. 
Sultana) lines were obtained and genetically analyzed. These lines had been 
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transformed with a gene expression cassette containing the Vv-AMP1 gene and a 
constitutive promoter, ensuring constitutive expression in all tissues. The transgenic 
population was genetically characterized to confirm the presence, integration and 
expression of the Vv-AMP1 transgene. Nine independently transformed lines with 
confirmed expression of the transgene were identified. Attempts to confirm the 
presence of Vv-AMP1 peptide in leaf, root and stem tissue were unsuccessful. As 
Western blot analysis remained inconclusive, the presence and antifungal activity of 
Vv-AMP1 in leaf tissue was directly evaluated through detached leaf infection 
assays.  
Despite the fact that B. cinerea was determined to be slightly more resistant to 
growth inhibition by Vv-AMP1 than other grapevine pathogens tested, it’s known 
ability to infect grapevine leaves and form lesions favored it as a first screening 
organism. 
Transgenic and control lines were infected with B. cinerea and after six days, a 
comparison of the transgenic lines with the control lines demonstrated that the 
transgenic lines performed marginally better than the untransformed controls. 
Further statistical analysis of the infection data revealed that the transgenic lines 
were statistically indistinguishable from one another and thus behaved as a 
population, and also that the transgenic lines were all statistically discernible from 
the control lines. This confirms that Vv-AMP1 is both present and active in the 
transgenic lines and that a resistance phenotype can be linked to the overexpression 
of Vv-AMP1 in the transgenic lines.  
Though enhanced resistance against B. cinerea is evident in the transgenic 
population, the level of improved resistance is still low. This marginal improvement in 
resistance may be ascribed to a number of contributing factors. B. cinerea is known 
to be slightly more resistant to Vv-AMP1 than other grapevine pathogens tested, with 
an established IC50 value of 13 µg/ml (De Beer and Vivier, 2008). If Vv-AMP1 is 
produced in the leaves of transgenic plants at levels that are relatively low, this could 
negatively affect the resistance phenotype. In addition, the harvesting of the leaves 
for the attached leaf assay induces a wound response, which in itself may inhibit or 
interfere with the effect of Vv-AMP1, thereby masking the defense phenotype linked 
to Vv-AMP1 overexpression.  
Also, the method of infection may need optimization with regards to leaf age, 
position and developmental stage, as these factors could all influence the 
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susceptibility of the plant to pathogen attack. B. cinerea has also been known to 
secrete a number of substances during infection of plant tissue. These substances 
(specifically proteases) may degrade the Vv-AMP1 peptide within the apoplastic 
environment, thereby interfering with the peptide’s ability to inhibit fungal growth.  
In conclusion, the availability of recombinantly produced and purified Vv-AMP1 
was necessary to facilitate in vitro antifungal assays against fungal pathogens. 
These in vitro studies revealed that Vv-AMP1 is highly active against grapevine-
specific pathogens. The establishment of a confirmed transgenic population 
overexpressing Vv-AMP1 increases the scope of evaluating the in vivo function of 
the peptide in grapevine, specifically in defense against infection from grapevine 
pathogens. Confirmation that the transgenic population showed an improved level of 
resistance against B. cinerea infection warrants further testing of the transgenic 
population against pathogens that are more sensitive to Vv-AMP1 (e.g. P. viticola) 
and those that can only be tested in in planta assays (e.g. downy and powdery 
mildew). Subsequent research and future work may ultimately lead to a stable 
transgenic grapevine with a significantly improved resistance against grapevine 
pathogens.   
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